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Abstract 
 
Leukocyte recruitment exhibits circadian, ~24h oscillations, which is dependent on 
local input by the sympathetic nervous system (SNS). Sympathetic nerves reach 
tissues alongside arterioles. Since smaller veins are devoid of sympathetic 
innervation but are the main site of leukocyte recruitment, it is unclear how these 
adrenergic stimuli reach veins to regulate leukocyte infiltration to tissues. Here, we 
demonstrate rhythmic differences in the ability of leukocytes to adhere to arteries 
and veins in an acute inflammatory scenario. Using in vivo quantitative imaging 
after TNF-α stimulation, we could observe higher leukocyte recruitment in the 
carotid artery in the morning and lower at night. It was the opposite situation in the 
case of the jugular vein; lower in the early morning and higher at night. We could 
confirm the same results in the microvasculature of the cremaster muscle, 
suggesting an intrinsic mechanism independent on the vessel location. Among 
different oscillatory cell adhesion molecules, intercellular adhesion molecule 1 
(ICAM-1) fitted most closely with the recruitment data. Using genetically modified 
mice and blocking antibodies, we could confirm the functional importance of ICAM-
1 in these oscillations in both vessels. As the SNS has in important role in rhythmic 
leukocyte recruitment, we next used pharmacological and surgical procedures for 
inducing denervation in our mice. We found ablated oscillations in leukocyte 
recruitment, as well as in Icam1 gene expression. Similar results were obtained 
when we focused on the β2 adrenergic receptors, via β2-antagonists and Adrb2-/- 
mice. Surprisingly, when using Ng2Cre x Bmal1flox/flox mice, where mice lacked a 
molecular clock specifically in arteriolar pericytes, we could no longer see 
oscillations in both vessels, even though the genetic manipulation targeted the 
artery. This suggested that there was an effect from the artery that could have 
affected the vein. In terms of clinical relevance, acute cardiovascular complications 
occur predominantly at the onset of the behavioral activity phase and are the major 
cause of death in humans. Recent evidence points to a critical role for rhythmic 
leukocyte recruitment in the onset of vascular diseases. We could see that altered 
rhythmicity resulted in a heightened susceptibility to vaso-occlusion at different 
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times. Together, these data point to an important role of arteries in regulating 
rhythmic leukocyte recruitment to veins, which could have potential implications in 
driving time-of-day-dependent cardiovascular complications. 
 
  
8 
 
Table of contents 
 
Acknowledgements ................................................................................................. 4 
Abstract ................................................................................................................... 6 
Abbreviations ......................................................................................................... 14 
1 Introduction ......................................................................................................... 18 
1.1 Cardiovascular system................................................................................. 18 
1.1.1 General overview .................................................................................. 18 
1.1.2 Vessels: differences between arteries and veins (structure and function)
 ....................................................................................................................... 20 
1.1.3 The leukocyte adhesion cascade .......................................................... 24 
1.2. Circadian rhythms ....................................................................................... 28 
1.2.1 General overview .................................................................................. 28 
1.2.2 Entrainment and synchronization of the clock ....................................... 29 
1.2.3 The molecular clock .............................................................................. 31 
1.2.4 Clock genes links to immunology .......................................................... 32 
1.2.5 Circadian rhythms and the immune system .......................................... 34 
1.2.6 Diseases associated with circadian rhythms ......................................... 39 
1.2.7 Shift workers and health complications ................................................. 40 
1.3 Sympathetic Nervous System ...................................................................... 41 
1.3.1 General overview .................................................................................. 41 
1.3.2 Role of the SNS in the vasculature........................................................ 42 
1.3.3 Adrenergic receptors ............................................................................. 44 
1.3.4 Adrenergic control of the immune system ............................................. 45 
2 Materials and Methods ....................................................................................... 48 
2.1 Animals ........................................................................................................ 48 
2.1.1 Mouse strains ........................................................................................ 48 
2.1.2 Genotyping ............................................................................................ 48 
2.1.3 Tamoxifen preparation and treatment ................................................... 51 
2.2 Multichannel fluorescence intravital microscopy (MFIM) .............................. 51 
2.2.1 Carotid artery and jugular vein imaging ................................................. 51 
9 
 
2.2.2 Cremaster muscle imaging .................................................................... 55 
2.3 Immunofluorescence on frozen sections ...................................................... 57 
2.4 Adoptive transfer and flow cytometry experiments ...................................... 60 
2.5 Functional blocking of adhesion molecules and chemokine receptors ........ 61 
2.6 Denervation techniques ............................................................................... 61 
2.6.1 Chemical sympathetic denervation (6-OHDA) ....................................... 61 
2.6.2 Surgical sympathetic denervation (SCGx) ............................................. 62 
2.7 β2 adrenergic receptor antagonist treatment ................................................ 62 
2.8 Thrombosis assay ........................................................................................ 63 
2.9 RNA isolation ............................................................................................... 64 
2.10 Reverse transcription ................................................................................. 64 
2.11 Quantitative real-time PCR ........................................................................ 65 
2.12 Statistical analyses .................................................................................... 67 
2.13 Antibody list ............................................................................................... 68 
2.14 Reagents ................................................................................................... 69 
3 Results ............................................................................................................... 71 
3.1. Differences in leukocyte adhesion between arteries and veins ................... 71 
3.2 Involvement of cell adhesion molecules and chemokines in diurnal leukocyte 
recruitment ......................................................................................................... 76 
3.3 Similar circadian oscillations in arteries and veins ....................................... 82 
3.4 Sympathetic control of circadian leukocyte recruitment in arteries and veins
 ........................................................................................................................... 86 
3.5 Differences in adrenergic input between arteries and veins ......................... 94 
3.6 Clinical relevance: circadian thrombosis ...................................................... 99 
4 Discussion ........................................................................................................ 104 
4.1. Circadian differences in leukocyte recruitment between arteries and veins
 ......................................................................................................................... 105 
4.2. Cell adhesion molecules and chemokines are involved in circadian 
recruitment ....................................................................................................... 106 
4.3. Differences in recruitment are independent of circadian clock gene 
expression ....................................................................................................... 107 
4.4 SNS controls rhythmic leukocyte recruitment in arteries and veins ........... 109 
10 
 
4.5 Arteries drive rhythmic recruitment in arteries and veins ........................... 110 
4.6 Different susceptibility in circadian thrombosis between arteries and veins111 
5 References ....................................................................................................... 114 
6 Appendix .......................................................................................................... 128 
6. 1 Curriculum Vitae ....................................................................................... 128 
6.2 Affidavit ...................................................................................................... 131 
 
  
11 
 
List of figures 
Figure 1.1 Cardiovascular System ................................................................................. 19 
Figure 1.2 Artery-vein network.. ..................................................................................... 20 
Figure 1.3 Structural features of the vasculature. ........................................................... 22 
Figure 1.4 General scheme of the leukocyte adhesion cascade. ................................... 26 
Figure 1.5 Entrainment and synchronization of the clock. .............................................. 30 
Figure 1.6 The molecular clock. ..................................................................................... 32 
Figure 1.7 Rhythms in immune cells parameters. .......................................................... 38 
Figure 1.8 Innervation status of the vasculature by SNS ................................................ 43 
 
Figure 2. 1 PCR genotyping gels .................................................................................... 50 
Figure 2. 2 Carotid artery/jugular vein in vivo imaging .................................................... 52 
Figure 2. 3 Epifluorescence microscope set-up.............................................................. 53 
Figure 2. 4 Representative example of mean fluorescence intensity measurement 
in adherent cells ............................................................................................................. 54 
Figure 2. 5 Cremaster muscle preparation ..................................................................... 55 
Figure 2. 6 MFIM of the cremasteric microcirculation ..................................................... 56 
Figure 2. 7 Cremaster muscle MFIM .............................................................................. 57 
Figure 2. 8 Representative fluorescence imaging picture ............................................... 58 
Figure 2. 9 Representative example of quantitative expression analyses ...................... 59 
Figure 2. 10 6-OHDA treatment scheme ........................................................................ 62 
Figure 2. 11 Set-up of phototoxicity-induced thrombus formation .................................. 63 
 
Figure 3.1 Diurnal oscillations in leukocyte adhesion in large vessels .................. 72 
Figure 3.2 Differences in leukocyte recruitment in LyEGFP mice between morning 
and night ............................................................................................................... 73 
Figure 3.3 Differences in leukocyte adhesion in microvasculature ........................ 74 
Figure 3.4 Differences in β2-integrins expression on adherent leukocytes ........... 75 
Figure 3.5 Relevance of the microenvironment in CFSE+ cells homing ................ 76 
Figure 3.6 Cell adhesion molecule oscillations after inflammation ........................ 77 
12 
 
Figure 3.7 Chemokine oscillations over 24h in an inflammatory scenario ............. 78 
Figure 3.8 ICAM-1 and VCAM-1 protein oscillations over 24h during inflammation
 .............................................................................................................................. 79 
Figure 3.9 Leukocyte recruitment to large vessels in Icam1-/- mice ....................... 80 
Figure 3.10 Importance of ICAM-1 and VCAM-1 in oscillatory recruitment in large 
vessels .................................................................................................................. 81 
Figure 3.11 Functional role of chemokines in oscillatory leukocyte recruitment in 
large vessels ......................................................................................................... 82 
Figure 3.12 PER2 daily oscillations in arteries and veins ...................................... 83 
Figure 3.13 Circadian clock genes oscillations in arteries and veins in steady state 
conditions .............................................................................................................. 84 
Figure 3.14 Circadian clock gene oscillations in arteries and veins in inflammatory 
conditions .............................................................................................................. 85 
Figure 3.15 Tnfr1 and Tnfr2 oscillations in large vessels ...................................... 86 
Figure 3.16 Leukocyte recruitment in animals with no sympathetic input .............. 87 
Figure 3.17 Leukocyte recruitment in animals after surgical denervation .............. 88 
Figure 3.18 Cell adhesion molecule expression after surgical denervation ........... 89 
Figure 3.19 Leukocyte recruitment in animals after acute β2 adrenergic receptor 
blockade ................................................................................................................ 90 
Figure 3.20 Icam1 expression after acute β2 adrenergic receptor blockade ......... 91 
Figure 3.21 Leukocyte recruitment in mice after chronic β2 adrenergic receptor 
blockade ................................................................................................................ 92 
Figure 3.22 Icam1 expression after chronic β2 adrenergic receptor blockade ...... 92 
Figure 3.23 Leukocyte recruitment in Adrb2-/- mice in inflammation ...................... 93 
Figure 3.24 Icam1 expression in Adrb2-/- mice ...................................................... 94 
Figure 3.25 Sympathetic innervation in large vessels ........................................... 95 
Figure 3.26 Sympathetic innervation in microvasculature ..................................... 96 
Figure 3.27 Tyrosine hydroxylase levels in large vessels ...................................... 96 
Figure 3.28 NG2 expression in large vessels ........................................................ 97 
Figure 3.29 NG2 expression in microvasculature .................................................. 97 
Figure 3.30 Leukocyte recruitment in Ng2Cre+ Bmal1flox/flox mice in inflammation 98 
13 
 
Figure 3.31 Icam1 expression in Ng2Cre+ Bmal1flox/flox mice ................................ 99 
Figure 3.32 L-selectin levels in adherent cells from arterioles and venules ......... 100 
Figure 3.33 Platelet-neutrophil interactions in arterioles and venules ................. 101 
Figure 3.34 Circadian thrombosis in venules and arterioles ................................ 102 
Figure 3.35 Circadian thrombosis in venules and arterioles from Ng2Cre+ 
Bmal1flox/flox mice ................................................................................................. 103 
 
 
List of tables 
Table 2.1 PCR reaction mix for genotyping. ................................................................... 49 
Table 2.2 PCR primers used for genotyping................................................................... 49 
Table 2.3 Primer sequences used for quantitative real time PCR .................................. 67 
Table 2.4 Antibody list .................................................................................................... 69 
Table 2.5 Reagents list ................................................................................................... 70 
 
  
14 
 
Abbreviations 
 
6-OHDA 6-hydroxydopamine 
ACTH Adrenocorticotropic hormone 
ANOVA Analysis of variance  
ANS Autonomic Nervous System 
APC Allophycocyanin 
AR  Adrenergic Receptors  
ARNTL  Aryl hydrocarbon receptor nuclear translocator-like protein  
BMAL1 Brain and muscle Arnt-like protein 1 
cAMP Cyclic adenosine monophosphate 
CAR CXCL12-abundant reticular 
CCL C-C chemokine ligand 
CCR  C-C chemokine receptor  
CD Cluster of differentiation  
cDNA Complementary deoxyribonucleic acid 
CFSE Carboxyfluorescein succinimidyl ester  
CLOCK Circadian locomotor output cycles kaput 
CNS Central Nervous System 
CRY Cryptochrome  
CT Circadian time 
CXCL C-X-C chemokine ligand 
CXCR  C-X-C chemokine receptor  
DC Dendritic cell 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
DβH Dopamine beta (β)-hydroxylase 
EC Endothelial cell 
EDTA Ethylenediaminetetraacetic acid 
15 
 
ESAM Endothelial cell-selective adhesion molecule 
ESL-1 E-selectin ligand-1 
FACS Fluorescence activated cell sorting 
FEV Forced expiratory volume 
FITC Fluorescein-5-isothiocyanate 
FLS Fibroblast-like synoviocytes 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase  
GFP Green fluorescent protein  
GR Glucocorticoid receptor 
HEV High endothelial venule 
HSC Hematopoietic stem cell 
HSPC Hematopoietic stem and progenitor cell 
i.p. Intraperitoneal 
i.v. Intravenous 
ICAM Intercellular adhesion molecule  
IFN-ɣ Interferon ɣ 
IL Interleukin 
ILC Innate lymphoid cell 
JAM Junctional adhesion molecule 
KO Knock-out 
LFA-1 Lymphocyte function-associated antigen 1 
LPS Lipopolysaccharide 
LXR Liver X receptor 
Ly6C Lymphocyte antigen 6 complex, locus C 
Mac-1 Macrophage antigen 1 
MadCAM-1 Mucosal vascular addressing cell-adhesion molecule 1 
MFI Mean fluorescence intensity  
MFIM Multichannel fluorescence intravital microscopy 
NE Norepinephrine 
NF Neurofilament 
NFκB Nuclear factor kappa B 
16 
 
NK Natural killer cell 
NKT Natural killer T cell 
OCT Optimal cutting temperature 
OVA Ovalbumin 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction 
PE Phycoerythrin 
PECAM-1 Platelet/endothelial-cell adhesion molecule 1 
PER Period circadian protein  
PI3K Phosphoinositide 3-kinase 
PNS Parasympathetic Nervous System 
PSGL-1 P-selectin glycoprotein ligand 1 
qPCR Quantitative polymerase chain reaction 
RA Rheumatoid arthritis 
RNA Ribonucleic acid 
RNase Ribonuclease 
SCG Superior cervical ganglion 
SCN Suprachiasmatic nuclei 
SEM Standard error of the mean 
SMA Smooth muscle actin 
SMC Smooth muscle cell 
SNS Sympathetic Nervous System 
TAE Tris-acetate-ethylenediaminetetraacetic acid 
TCR T cell receptor 
TE Tris-EDTA 
Th T helper cell 
TH Tyrosine hydroxylase 
TLR Toll-like receptor 
TNF-α Tumor necrosis factor-α 
VCAM Vascular cell-adhesion molecule  
VLA4 Very late antigen 4 (also known as α4β1-integrin) 
17 
 
VPAC2 Vasoactive intestinal peptide receptor 2 
WT Wild type 
ZT Zeitgeber time  
βAR β-adrenergic receptor 
 
  
18 
 
1 Introduction 
 
1.1 Cardiovascular system 
 
1.1.1 General overview 
 
The heart, blood and the vasculature (arteries, veins and capillaries) are the 
principal components of the cardiovascular system. Its most important function is to 
transport oxygenated blood, with nutrients, immune and other functional cells to the 
body’s periphery and collect the poorly oxygenated blood and waste products. 
Through the pulmonary artery, blood is pumped from the right ventricle of the heart 
to the lungs, where it is oxygenated.  Simultaneously, oxygenated blood from the 
lungs is pumped to the periphery of the body from the left ventricle of the heart 
through the aorta. Arteries are therefore the blood vessels that transport blood 
away from the heart, while veins transport blood back to the heart as we can see in 
the Figure 1.1 where these processes are illustrated. Capillaries carry blood within 
tissues and are the exchange sites of nutrients, gases, and other products (Lilly, 
2010). 
The aorta is the main artery in the body and developmentally gives rise to the rest 
of the arteries, with the exception of pulmonary arteries. It branches to form large 
arteries and from these, smaller arteries are embedded in tissues. These finally 
branch into the small-diameter arterioles, the resistance vessels that are critical 
mediators of blood pressure. On the venous side, the narrowest vessels are 
venules. These vessels merge to form veins, which finally converge to create the 
two largest veins of the body: the venae cavae (superior and inferior). Capillaries 
are the smallest vessels of the body and form the connection between arterioles 
and venules. A simplified scheme of the artery-vein network is shown in Figure 
1.2. 
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Figure 1.1 Cardiovascular System. Oxygenated blood from the lungs is pumped by the 
heart to the rest of the body through the aorta, which branches into smaller arteries, 
arterioles and finally into capillaries, where the gas exchange occurs. These capillaries 
merge and form venules and veins, to finally culminate in the superior and inferior vena 
cava that bring back poorly oxygenated blood to the heart. From here, the pulmonary 
arteries transport blood to the lungs to be re-oxygenated. Modified from (Pearson 
Education, 2011). 
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Figure 1.2 Artery-vein network. Arteries branch into smaller arteries and arterioles. On 
the contrary, venules merge into larger veins and then into the vena cava. Capillaries are 
the smallest vessels in the body and form the connection between arterioles and venules. 
Adapted from (Rogers, 2017). 
 
With the exception of capillaries, all blood vessels share the same basic structure 
consisting of three layers: outer layer or tunica externa, middle layer or tunica 
media and inner layer or tunica intima (Fawcett, 1994). However, there are some 
remarkable differences between arteries and veins, as discussed below. 
 
1.1.2 Vessels: differences between arteries and veins (structure and 
function) 
 
In terms of structure, arteries and veins show several differences (Figure 1.3): 
- Size: Arteries are smaller in diameter than veins but their walls are much 
thicker (dela Paz and D'Amore, 2009). 
- Tunica externa (adventitia): This layer is composed of connective tissue, 
collagen and elastic fibers. In the case of large vessels, they even have their 
own blood supply (vasa vasorum).  Smooth muscle cells (SMCs) are 
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orientated in a longitudinal fashion. While in veins the adventitia is the major 
part of the vessel wall, in arteries or arterioles it represents only half of the 
total thickness (dela Paz and D'Amore, 2009). 
- Tunica media: Formed by circumferentially orientated SMCs that provide 
muscular support, in addition to some elastic fibers. In arteries, this layer is 
thicker and there is an additional external elastic lamina, which is not clearly 
defined in veins. As a consequence, walls in veins are thinner and less rigid. 
These conditions allow arteries to work at higher pressures than veins. On 
the other hand, due to their capacity to expand, veins hold a much larger 
proportion of the blood than arteries (dela Paz and D'Amore, 2009). 
- Tunica intima: This layer is formed by the endothelium and a supportive 
matrix of connective tissue (collagen and elastic fibers). In the case of 
arteries, there is an additional internal elastic layer present between the 
intima and the media, which is absent in veins. In addition, the presence of 
valves that avoid the backflow of blood is an exclusive characteristic of large 
veins (dela Paz and D'Amore, 2009). 
- Endothelial cells (ECs): These cells show different size and shape 
depending on the vascular bed they belong to. Arteriolar ECs are elongated 
and narrow compared to venous ECs, which are short and wide (Florey, 
1966). In addition, the arteriolar ECs are thicker than venous ones with the 
exception of ECs from high endothelial venules (HEVs), situated within 
lymph nodes (Girard et al., 2012). Another difference is the shear stress 
they are exposed to, being higher in the case of the arteries and arterioles 
than in veins and venules.  
- Intercellular junctions: Three different types can be defined, described as 
tight junctions (zona occludens), adherens junctions (zona adherens) and 
gap junctions (cell-cell communications) (Bazzoni and Dejana, 2004). These 
three structures are much tighter and are more highly organized in arteries 
than in veins. 
- Lumen: Arteries have a much narrower lumen, which contributes to the 
maintenance of higher blood pressures in these vessels. 
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- Sympathetic innervation of vessels: Sympathetic innervation is present in all 
blood vessels except capillaries and post-capillary venules (Krams, 2017). 
In the case of rats, however, the peripheral nervous system follows a similar 
structure as the arteries, branching together. From these main nerve trunks, 
small branches emerge and connect with the network of varicosed 
adrenergic fibers, which surround the main artery. Contrary to the arteries, 
veins are lacking adrenergic innervation (Marshall, 1982).  
 
 
 
Figure 1.3 Structural features of the vasculature. With the capillaries as an exception, 
all blood vessels are composed of three layers: tunica intima (composed of endothelial 
cells), tunica media (SMCs and elastic fibers) and tunica adventitia, which contains elastic 
fibers, collagen and connective tissue. Whereas arteries and arterioles exhibit an internal 
and an external laminal layer, veins and venules are devoid of this structure. Modified from 
(dela Paz and D'Amore, 2009). 
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Additional differences between arteries and veins exist at the functional level: 
- Blood direction: As previously described, arteries carry blood away from the 
heart while veins carry blood towards it. 
- Blood oxygenation: Contrary to veins and with the exception of the 
pulmonary artery, arteries carry oxygenated blood from the heart towards 
the body. 
- Function of the endothelium: Arteries and arterioles are able to modify their 
vascular tone through vasodilation and vasoconstriction (relaxation or 
constriction of the SMCs in the tunica media), changing their vascular 
resistance and blood pressure. On the other hand, veins, mainly post-
capillary venules, are able to change their permeability during inflammation 
in response to agonists such as histamine and serotonin (Majno and 
Palade, 1961). Another factor that increases the permeability in veins is the 
lack of well-structured tight junctions. 
- Leukocyte trafficking: Rolling, firm adhesion and transmigration are the main 
steps of the leukocyte adhesion cascade. This event is almost exclusive to 
post-capillary venules due to its lower flow rate, thinner walls, fewer tight 
junctions and higher expression of cell adhesion molecules. However, 
depending on the organ, leukocyte recruitment can also occur in capillaries, 
as is the case in the lung (Looney and Bhattacharya, 2014). The adhesion 
cascade will be discussed in the next part of this Introduction. 
 
Apart from the structural and functional differences associated with blood flow, 
blood pressure or blood oxygenation, there is a diverse gene expression profile 
between arteries and veins. There is a molecular discrepancy between arterial and 
venous ECs, which appears to be intrinsic and not related to the environmental 
conditions. This suggests an early diversion in the development of both vascular 
beds, an event that has been linked to Notch signaling pathways and involving the 
Hey2 transcription factor (Chi et al., 2003). 
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1.1.3 The leukocyte adhesion cascade 
 
Inflammation is a crucial process that occurs in the body in response to different 
stimuli such as infections or after injuries. Leukocyte recruitment to tissues is a 
critical event that takes place during the inflammatory response. Leukocytes 
become activated and extravasate from blood to tissues in a sequence of distinct 
steps known as the leukocyte adhesion cascade. Many studies have investigated 
this process, which can be summarized in the sequence of the following steps: the 
capture and rolling of leukocytes, their slow rolling, firm adhesion, crawling and 
transmigration (paracellular or transcellular) as shown in Figure 1.4. 
- Capture/Rolling: This is the initial step in the cascade and occurs after 
endothelial cell activation, but in some vascular beds, such as the skin, this 
also takes place in steady-state conditions. Endothelial cells express E- and 
P- selectin. These proteins bind to their ligand on the leukocyte, P-selectin 
glycoprotein ligand-1 (PSGL-1), which was initially thought to interact 
uniquely with P-selectin. Apart from PSGL-1, E-selectin binds to CD44 and 
E-selectin ligand-1 (ESL-1) in neutrophils (Hidalgo et al., 2007). 
- Slow rolling: This step requires the expression of E-selectin on endothelial 
cells (Jung and Ley, 1999) and CD18/β2 integrins on the rolling leukocytes 
(Jung et al., 1998) and has been termed "slow rolling" to differentiate it from 
the much faster rolling that occurs without cytokine stimulation. There are 
different kinds of β2 integrins, but the most relevant in this step are the 
lymphocyte function-associated antigen 1 (LFA-1) and the macrophage 
receptor 1 (Mac-1), whose ligand are ICAM-1, ICAM-2 and ICAM-3. Studies 
have described a change in the conformation of LFA-1 and therefore a 
higher ligand-binding affinity of the integrin under shear stress, suggesting 
the importance of LFA-1 in this step (Astrof et al., 2006). However, although 
this step of the cascade facilitates recruitment, it is not required, as high 
concentrations of chemoattractants are also able to arrest fast-rolling cells 
(Scharffetter-Kochanek et al., 1998). 
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- Firm adhesion: Due to the rolling step, leukocytes come in close contact 
with the endothelium and thus are able to interact with endothelial cell 
surface-bound chemokines, which are strongly induced by inflammatory 
mediators.  As a consequence of the binding of chemokines to their 
receptors on leukocytes, an inside-out signaling cascade activates 
leukocyte integrins (Charo and Ransohoff, 2006). Studies in humans 
(Anderson and Springer, 1987) and mice (Wilson et al., 1993) suggest the 
importance of LFA-1 and Mac-1 in this process, since deficiencies in these 
β2-integrins lead to impaired leukocyte recruitment and an associated 
increase in bacterial infections. However, in vivo studies showed that LFA-1 
is the most important β2 integrin in firm adhesion, while Mac-1 seems to be 
more relevant in neutrophil activation and phagocytosis (Lu et al., 1997). 
LFA-1 and Mac-1 bind to endothelial ICAM-1 and ICAM-2 (Hogg et al., 
2002), which are constitutively expressed. ICAM-1 expression can 
additionally be strongly enhanced after endothelial cell activation (Dustin et 
al., 2011). In contrast, endothelial cell vascular cell-adhesion molecule 1 
(VCAM-1) is recognized by β1 integrins very late antigen 4 (VLA-4), 
particularly expressed by lymphocytes and monocytes (Elices et al., 1990). 
- Transmigration: This is the final step in the leukocyte adhesion cascade 
and the one that is the least understood. In the case of lymphocytes, 
leukocyte transmigration has been shown in vitro to be initiated by dynamic 
interactions between adherent leukocytes and endothelial cells forming 
‘docking structures’ consisting of VCAM-1 and ICAM-1 (Barreiro et al., 
2002). Two different types of transmigration routes have been described: 
paracellular, if the leukocyte is migrating from blood to tissues between two 
endothelial cells, and transcellular, if the migration occurs through the body 
of endothelial cells. 
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Figure 1.4 General scheme of the leukocyte adhesion cascade. Leukocytes are 
captured and start to roll along the endothelium due to the expression of selectins. 
Chemokines play an important role in firm adhesion and activation, whereas in the 
crawling step, integrins are the key molecules. Leukocytes transmigrate through the 
endothelium following a chemokine gradient. Crucial molecules involved in each stage are 
specified in boxes. ESAM, endothelial cell-selective adhesion molecule; ICAM, intercellular 
adhesion molecule; JAM, junctional adhesion molecule; LFA-1, lymphocyte function-
associated antigen 1 (also known as αLβ2-integrin); Mac-1, macrophage antigen 1; 
MadCAM-1, mucosal vascular addressin cell-adhesion molecule 1; PSGL-1, P-selectin 
glycoprotein ligand 1; PECAM-1, platelet/endothelial-cell adhesion molecule 1; PI3K, 
phosphoinositide 3-kinase; VCAM-1, vascular cell-adhesion molecule 1; VLA-4, very late 
antigen 4 (also known as α4β1-integrin). Adapted from Ley et al, (Ley et al., 2007). 
 
Leukocyte recruitment is predominantly a venular process but some studies have 
reported that under inflammatory conditions barrier function is also altered in 
arterioles and adhesion molecules are upregulated in order to support leukocyte 
and platelet interactions. This indicates that arterioles can also contribute to 
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inflammatory responses in addition to their role in blood flow regulation (Sumagin 
and Sarelius, 2013). However, this process appears to be mostly restricted to 
intravascular events. 
ICAM-1 is a very important molecule in leukocyte-endothelial interactions and, as 
for other adhesion molecules, the mechanism of its upregulation in veins is the 
same as the one in arteries (Nabah et al., 2005) but its distribution is different 
between the two vessels. While venular endothelium expresses higher ICAM-1 
levels in steady-state conditions, contributing to leukocyte adhesion, arteriolar 
ICAM-1 was found to be present in lower amounts. This could be a potential 
reason for the lack of leukocyte adhesion in arterioles under normal situations. 
Another explanation for the reduced frequency of arteriolar adhesion may lie in the 
fact that the luminal surface area of arteriolar ECs is roughly twice that of venular 
ECs, so they might simply not reach sufficient surface density levels of ICAM-1 
(Sumagin and Sarelius, 2006).    
However, Sumagin and colleagues showed that ICAM-1 could support rolling but 
not adhesion in arterioles, suggesting an important role in the initial phases of the 
inflammatory cascade. They also hypothesized that in arterioles, both leukocyte 
rolling and increased levels of ICAM-1, rather than leading to adhesion and 
transmigration, might have a different functional outcome (Sumagin and Sarelius, 
2007). Another study has linked the rolling step in arterioles with P-selectin (Nabah 
et al., 2005). Together, it seems that the contribution of arterioles to inflammatory 
responses is restricted to the initial steps of the process. 
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1.2. Circadian rhythms  
 
1.2.1 General overview 
 
Organisms have acquired biological clocks during evolution as time-keeping 
mechanism in order to adapt to their rhythmic environment. Depending on 
frequency, there are different categories of rhythms in mammals: ultradian, which 
last from seconds to hours, like blood circulation, pulse and hormonal secretions 
(Tannenbaum and Martin, 1976); circadian, of about 24 hours; and infradian, which 
exhibit longer periods than 24h, such as menstruation cycles, breeding or seasonal 
rhythms (Hoppensteadt and Keller, 1976). 
Circadian rhythms are endogenous oscillations of about 24h (from the Latin, circa 
= about, diem = day) that operate in all light-sensitive organisms (Mauvoisin et al., 
2015). They are involved in diverse biological functions such as physiology, 
behavior and metabolism and can be found at multiple levels, from the whole 
organism to different tissues and also at the molecular level, as virtually every cell 
carries an intrinsic molecular clock. There are different external cues, known as 
Zeitgebers, for the organism to synchronize their internal clock to the environment, 
such as food, temperature or light. For a rhythm to be termed circadian, one 
important characteristic is that it must oscillate in a constant environment (i.e. 
devoid of zeitgebers like light-dark cycles, also known as free-running conditions). 
The other two criteria are that they must be entrainable and exhibit temperature 
compensation (Golombek and Rosenstein, 2010). In addition, there is a distinction 
between the terminology zeitgeber time (ZT) and circadian time (CT). ZT is a unit 
of time based on the period of a zeitgeber, for instance, the light:dark cycle. In a 
light:dark cycle, for diurnal organisms ZT0 (lights on) is the time of activity onset 
and ZT12 (lights off) defines activity onset for nocturnal animals. On the other 
hand, CT refers to a standard unit of time based on the endogenous free-running 
period of a rhythm. By agreement, in free-running, constant conditions, the 
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beginning of activity of day-active organisms is circadian time zero (CT0) and the 
start of activity of night-active organisms is CT12 (Karatsoreos and Silver 2017). 
 
1.2.2 Entrainment and synchronization of the clock 
 
As mentioned above, different external cues (Zeitgebers) are able to synchronize 
the clock. The most important of these cues is light (Aschoff, 1960). Light 
additionally indirectly affects food intake as it sets the wake-sleep cycle. In the 
case of mammals, which are opaque individuals, light detection by the eye is 
essential to transmit the lighting information to the central pacemaker in the brain. 
Light is processed through the retina and this signal is transduced via the 
retinohypothalamic tract to the central (or master) clock of the organism, located in 
the suprachiasmatic nuclei (SCN) of the hypothalamus (Golombek and Rosenstein, 
2010). The SCN are composed of about 20.000 neurons, which together are 
considered the pacemaker of the organism (Ralph et al., 1990). From here, signals 
can be relayed to the rest of the body via different routes: humoral or neural. On 
the one hand, adrenocorticotropic hormone (ACTH), released by the pituitary 
gland, targets the adrenal glands, leading to a circadian release of glucocorticoids 
and catecholamines (noradrenaline and adrenaline). On the other hand, the 
sympathetic nervous system (SNS) directly innervates peripheral organs and 
tissues and may orchestrate their clocks via local noradrenaline secretion from 
nerve varicosities (Dickmeis, 2009) (Figure 1.5). 
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Figure 1.5 Entrainment and synchronization of the clock. Light is the most important 
external cue used to synchronize the organism with its rhythmic environment. It is sensed 
through the eye, which signals via the retinohypothalamic tract to the suprachiasmatic 
nuclei (SCN), where the central clock is located. From here, there are two ways of 
transmitting the signal, hormonal or via direct innervation of the SNS. Adrenocorticotropic 
hormone (ACTH) is released from the pituitary gland and targets the adrenal gland, which 
secretes other hormones such as glucocorticoids, adrenaline and noradrenaline in a 
circadian manner. The SNS innervates directly organs such as the bone marrow, liver and 
spleen and through its varicosities can secrete noradrenaline. Modified from Scheiermann 
et al., 2013. 
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1.2.3 The molecular clock 
 
At the molecular level, the clock is a highly complex machinery consisting of 
multiple transcription factors that together produce auto-regulatory transcription-
translation feedback loops, where photic input plays a role in synchronizing the 
transcription of the clock genes.  
The core clock genes are Clock (circadian locomotor output cycles kaput) and 
Bmal1 (brain and muscle Arnt-like protein 1, encoded by Arntl), which encode for 
the proteins CLOCK and BMAL1. These proteins dimerize in the cytoplasm and 
this heterodimer is then translocated to the nucleus where it binds to canonical 
enhancer-boxes (E-box) of the negative regulators of the clock (Per1/2, Cry1/2, 
Nr1d1/2). In addition, the heterodimer BMAL1-CLOCK controls the transcription of 
clock-controlled genes such as Dbp, which binds D-boxes and thus can influence 
additional downstream genes (Bunger et al., 2000). Period circadian protein (PER) 
and cryptochrome (CRY) form a heterodimer to repress their own expression, 
forming the negative branch of the auto-regulatory feedback loop (Shearman et al., 
2000). A second loop includes the circadian regulation of Bmal1 transcription by 
the transcription factors REV-ERBα/β (encoded by Nr1d1 and Nr1d2) (Preitner et 
al., 2002) and ROR (Alvarez et al., 2003), where BMAL1 transcription is indirectly 
inhibited (Figure 1.6). 
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Figure 1.6 The molecular clock. Core clock genes Bmal1 (brain and muscle aryl 
hydrocarbon receptor nuclear translocator (ARNT)-like 1) and Clock (circadian locomotor 
output cycles kaput) are transcribed to BMAL1 and CLOCK transcription factors, which 
form a heterodimer that binds E-box sequences of clock-controlled genes. This system is 
auto-regulated through negative feedback loops, as BMAL1 and CLOCK inhibit the 
transcriptional activity of CLOCK and BMAL1 (Druzd et al., 2014).  
 
 
1.2.4 Clock genes links to immunology 
 
From an immunological perspective, there are a number of examples that link the 
clock with the immune system. Deficiencies in clock genes can lead to anti- or pro-
inflammatory properties as shown in diverse immune phenotypes of clock gene 
knock-out mice.  
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‘Anti-inflammatory’ clock genes:  
- Bmal1: The absence of this core clock gene results in a complete loss of 
circadian rhythmicity in constant darkness and also under light-dark conditions 
(Bunger et al., 2000). In another publication, it was shown the lack of oscillations in 
either CXCR4 or CXCL12 in bone marrow (Lucas et al., 2008) (Mendez-Ferrer et 
al., 2008). In addition, reduced numbers of B cells in peripheral blood, spleen and 
bone marrow (Sun et al., 2006). When lack of Bmal1 was restricted to myeloid 
cells, using LysM-Cre x Bmal1flox/flox mice, the time-dependent response to 
lipopolysacchadire (LPS) IL-6 expression was not rhythmic and high (Gibbs et al., 
2012). This was accompanied by an increase of inflammatory cytokines and 
chemokines (IL-1β, IL-6, INF-γ and CCL2). In the case of the study conducted by 
Nguyen and colleagues, a higher number of Ly6hi monocytes was noticed when 
targeting specifically myeloid cells (Nguyen et al., 2013). 
- Cry: Increased levels of the pro-inflammatory cytokines IL-6, TNF-α as well as 
iNOS, enhanced NFκB activation and a stronger response to LPS have been 
reported in the double knock out mice for both CRY proteins (Cry1-/- Cry2-/- mice) 
(Narasimamurthy et al., 2012). In the single Cry1 KO mice (Cry1-/- mice), increased 
joint swelling in an arthritis model was observed (Hashiramoto et al., 2010). 
Another evidence of the anti-inflammatory role of Cry was described in an article 
related to rheumatoid arthritis (RA), where they used fibroblast-like synoviocytes 
(FLS) cells, crucial effector cells in this disease. FLS cells from the double KO mice 
showed a significantly enhanced inflammatory response, at both the gene (Il6, 
Cxcl5, and Il1β) and protein (CXCL1, IL6, and CXCL5) level after TNFα stimulation 
(Hand et al. 2016).  
- Rora: A defect in T and B cell development has been shown in Rora-/- mice and, 
in response to LPS stimulation, mast cells showed a stronger IL-6 and TNF-α 
production (Dzhagalov et al., 2004). 
- RevErbα: Nr1d1-/- mice showed a loss of circadian IL-6 expression in response to 
LPS stimulation (Gibbs et al., 2012). However, Th17 cell differentiation was shown 
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to be promoted in these mice, which would have an anti-inflammatory effect, 
suggesting a role for this gene in pro-inflammatory responses as well (Yu et al., 
2013). 
 
‘Pro-inflammatory’ clock genes: 
- Clock: Clock-/- mice showed reduced nuclear accumulation of p65 associated with 
reduced NF-κB activation (Spengler et al., 2012). In addition, Bellet and colleagues 
reported a lower response to LPS in mouse embryonic fibroblasts (Bellet et al., 
2012) and bone marrow derived macrophages (Bellet et al., 2013) as well as a 
reduction in the gut colonization of Salmonella enterica.  
- Per: In the case of Per1-/- mice, an altered circadian expression of cytokines such 
as IFN-γ and cytolytic factors in splenic natural killer (NK) cells were described 
(Logan et al., 2013). In Per2 mutant mice there was a decreased serum 
concentration of IFN-γ during the day (Arjona and Sarkar, 2006), as well as 
reduced production of IL-1β in response to LPS challenge due to a defect in NK 
and NKT cell function (Liu et al., 2006). 
 
1.2.5 Circadian rhythms and the immune system 
 
As mentioned above, there is a strong link between clock genes and inflammation 
as many mice deficient in clock genes show alterations in immune phenotypes. In 
addition, different immuno-modulatory parameters such as cytokines, chemokines, 
chemokine receptors and cell adhesion molecules fluctuate according to the time 
of the day. This is also the case for the numbers of circulating leukocytes. 
Oscillations in the immune system will be discussed in the next section. 
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1.2.5.1 Circadian control of inflammatory mediators 
- Cytokines: several cytokines have been reported to oscillate in a rhythmic 
manner in response to an inflammatory stimulus. For instance, IL-1β peaks 
at ZT8 and drops at ZT12 in peritoneal fluid (Nguyen et al., 2013), IL-5 has 
its acrophase at ZT3 and its trough 12h later in serum (Nussbaum et al., 
2013), and IL-6 and IL-12 are mostly released at CT12 (Gibbs et al., 2012) 
in mice. In a study analyzing human serum from healthy individuals, 
fluctuations in IL-2, IL-10, GM-CSF and TNF-α were reported (Young et al., 
1995), suggesting that, even in steady-state conditions, there are 
oscillations of these pro-inflammatory mediators.  
- Chemokines: Gibbs and colleagues have described peaks at CT12, with the 
same pattern, in the levels of CCL2, CCL5 and CXCL1 in serum from mice 
injected with LPS (Gibbs et al., 2012). Expression of CXCL12, a chemokine 
important for HSCs homing to the bone marrow, was shown to be higher 
during the active phase of mice (Mendez-Ferrer et al., 2008). 
- Chemokine receptors: CXCR4, the receptor for CXCL12, has been reported 
to oscillate - peaking at ZT13 in circulating HSCs (Lucas et al., 2008) and at 
ZT17 in murine neutrophils (Casanova-Acebes et al., 2013) during 
homeostasis. Similar observations for CXCR4, but at inverted times, were 
found in human T cells, as well as for CX3CR1 in CD8 T cells (Dimitrov et 
al., 2009). 
- Adhesion molecules: L-selectin expression changes over 24h in neutrophils 
(Casanova-Acebes et al., 2013). ICAM-1 peaks at the onset of the activity 
phase in muscle endothelial cells, as well as E-Selectin, P-Selectin and 
VCAM-1 in endothelial cells from bone marrow (Scheiermann et al., 2012). 
 
1.2.5.2 Circadian control of immune cell trafficking 
In contrast to circulating erythrocytes and platelets, whose numbers do not 
oscillate, leukocyte counts follow a 24h pattern in blood. Higher numbers are found 
36 
 
during the behavioral rest phase of the organism which in rodents is during the day 
and for humans occurs at night (Druzd et al., 2014).  
Among cells of the innate immune system, monocytes have been shown to 
oscillate in murine blood across the day. In a study performed by Nguyen and 
colleagues, Ly6CHI inflammatory monocytes exhibited diurnal variation, controlling 
their trafficking to places of inflammation. These oscillations were regulated by the 
repressive activity of the circadian gene Bmal1 and this conferred an advantage 
against Listeria monocytogenes infection (Nguyen et al., 2013).  
Similar to monocytes, the number of neutrophils in blood is higher during the day 
than during the night. CD62HI neutrophils represent young cells that have just been 
released into blood from the bone marrow and, as the day passes, these become 
CD62LO CXCR4HI (aged neutrophils). Aged neutrophils migrate back to the BM 
towards the end of the day where they are phagocytosed by macrophages. This 
leads to the activation of the macrophages and liver-X-receptors (LXR), which 
reduce the number of niche cells and the quantity of CXCL12, thereby promoting 
the release of HSCs to the blood circulation (Casanova-Acebes et al., 2013). This 
suggests neutrophil migration is closely linked to HSC biology. 
The number of circulating eosinophils is also rhythmic. Circadian cycling of 
eosinophils has been shown to be due to oscillatory IL-5 secretion by innate 
lymphoid cells (ILC2) from peripheral tissues. A circadian intestinal peptide 
stimulates ILC2 cells through the vasoactive intestinal peptide receptor (VPAC2) 
receptor and increasing IL-5 release, thus linking eosinophil levels to metabolic 
cycling (Nussbaum et al., 2013). 
Among cells of the adaptive immune system, T lymphocyte numbers in human 
blood have been shown to depend on circulating cortisol and catecholamines, 
which are rhythmically secreted. Naïve T cell numbers were lower during the day, 
and thus negatively correlated with cortisol levels. These cells though showed the 
highest CXCR4 expression. Actually, a recent publication described the importance 
of glucocorticoid regulation in diurnal CXCR4 oscillations (Shimba et al. 2018). In 
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contrast, the number of CD8 T cells was directly correlated with adrenaline rhythms 
(Dimitrov et al., 2009). 
A study conducted by Fortier and colleagues demonstrated that the T cell response 
to a T cell receptor (TCR) stimulus varies in a circadian manner. These differences 
were not due to the daily variation in the number of T cell subsets either in the 
lymph nodes or the expression levels of the TCR. The authors demonstrated 
instead that a circadian variation exists in the protein levels of the TCR-associated 
kinase ZAP70. In addition, they showed in vivo that the antigen-specific response 
of T cells is influenced by the timing of immunization (Fortier et al., 2011). 
Day-night differences in the response of CD4+ T cells to immunization have also 
been reported, where mice were immunized with ovalbumin (OVA) in the presence 
of CpG oligodeoxynucleotides, a ligand for Toll-like receptor 9 (TLR9). This 
receptor is expressed at high levels during the active phase of the mice (night), 
which leads to a stronger response of T cells due to an enhanced activation of 
antigen presenting cells expressing TLR9 (Silver et al., 2012). A summary with 
different examples of rhythms in immune parameters can be visualized in the 
Figure 1.7, modified from a Review from Druzd and colleagues (Druzd et al., 
2014). 
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Figure 1.7 Rhythms in immune parameters. There are oscillations in the number of 
leukocytes and their activation status in different immune tissues according to the phase of 
activity (active during the night and resting during the day in mice). In the spleen, the 
number of macrophages is higher at night and those macrophages express more TLR9 
receptors, which, in response to stimuli such as bacterial DNA, secrete larger quantities of 
pro-inflammatory molecules such as TNF-α and IL-6. In blood, all hematopoietic 
progenitors and leukocyte subsets are more abundant during the day whereas 
erythrocytes and platelets do not strongly oscillate. In bone marrow, there is higher 
hematopoietic stem cell (HSC) recruitment due to a higher number of CXCL12-abundant 
reticular (CAR) and Nestin+ cells, which release CXCL12 in a circadian manner. In skeletal 
muscle (cremaster muscle), there is a higher expression of ICAM-1 and CCL2 during the 
active phase that leads to an enhanced leukocyte infiltration to this tissue. Modified from 
(Druzd et al., 2014). 
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1.2.6 Diseases associated with circadian rhythms 
 
Several diseases show circadian rhythmicity, meaning that their symptoms differ 
across the day. This is the case for diverse chronic inflammatory diseases, such as 
rheumatoid arthritis (RA), asthma or allergic reactions. Patients with RA show an 
increase in joint pain and stiffness between 05:00 and 08:00am, which has been 
linked to higher serum levels of the pro-inflammatory cytokines IL-6 and TNF-α 
(Straub and Cutolo, 2007; Cutolo, 2012). In healthy subjects, serum levels of TNF-
α and IL-6 have already begun to decrease at 6:00 and 9:00am respectively, 
whereas in RA patients these levels remain elevated until 10:00 and 11:00am 
(Straub and Cutolo, 2007). IL-6 has also been linked to a predisposition to 
thrombosis, as the highest prevalence occurs at the same time, from 6:00 to 
9:00am in the morning, coinciding with a higher activation status of functional 
platelets (Undar et al., 1999). Another reason could be the role of IL-6 as 
coagulation stimulator (Stouthard et al., 1996).  
Similarly, cardiovascular diseases such as myocardial ischemia (Mulcahy et al., 
1988; Parker et al., 1994) and infarction (Muller et al., 1985) present a higher risk 
during the morning. This has been associated with changes in adrenergic activity, 
systemic arterial pressure, heart rate, vascular tone and coagulability (Tofler et al., 
1995). However, leukocytosis is also associated with thrombotic events and some 
studies have linked the importance of leukocyte recruitment to vaso-occlusive 
crises in a mouse model of sickle cell disease (Hidalgo et al., 2009; Scheiermann 
et al., 2012).   
In addition, later work shows that there are more infarcts in the morning and that 
the infarct sizes were found to be larger at that particular time of the day, 
suggesting a contributing role for a circadian leukocyte infiltration in these events 
(Suarez-Barrientos et al., 2011). Another observation that supports this hypothesis 
is that the number of leukocytes in blood correlates with an increased morbidity 
and mortality of ischemic vascular disease (Coller, 2005). In fact, in a recent 
publication by Schloss and colleagues, the authors described how CCR2 surface 
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expression on Ly6CHI monocytes fluctuates in a rhythmic manner, significantly 
influencing cardiac monocyte recruitment after an acute ischemic event (Schloss et 
al., 2017). 
In contrast, nocturnal asthma reaches its climax at night, at around 04:00am, when 
symptoms such as cough, dyspnea, airflow limitation, airway hyper-responsiveness 
and sudden death are exacerbated. Although lung function fluctuates over the 24h 
period in healthy individuals, these fluctuations are greatly exaggerated in patients 
with nocturnal asthma, with differences in forced expiratory volume (FEV) and 
expiratory flow rate between wakefulness and sleep. In addition, alveolar tissue 
from patients with nocturnal asthma showed a greater number of eosinophils and 
macrophages at 04:00am as reviewed in this publication by (Litinski et al., 2009). 
Taking into consideration the specific occurrences of these events would be useful 
in the field of chronopharmacology, the time-of-day-dependent administration of 
drugs, in order to improve the existing therapies of inflammatory diseases or 
incorporate the possibility of time-dependent treatments. 
 
1.2.7 Shift workers and health complications 
 
Over the last few decades, the importance of the maintenance of circadian rhythms 
in health has been elucidated. Alterations in these rhythms can lead to a 
malfunction of the immune system. This has been suggested to be an important 
reason why shift workers are more prone to develop certain diseases such as 
cancer or cardiovascular problems. 
Risk of multiple types of cancer has been reported to be increased due to shift 
work. For instance, colorectal cancer is more prevalent in nurses (Schernhammer 
et al., 2003) and shift workers (Mormont et al., 2000). Similar associations were 
observed with respect to breast cancer in premenopausal nurses (Schernhammer 
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et al., 2006) and women who worked at night (Hansen, 2001), as well as prostate 
cancer in working men in Japan (Kubo et al., 2006). 
Regarding cardiovascular complications, coronary heart disease also shows a 
higher prevalence in shift workers, in combination with other adverse lifestyle 
factors (Tenkanen et al., 1998). Atherosclerosis and myocardial infarction can also 
be exacerbated by shift work (Haupt et al., 2008). 
Taken together, these studies provide evidence for a negative effect of shift work 
upon health, due to a dysregulation in the alignment of workers’ internal clocks.  
 
 
1.3 Sympathetic Nervous System 
 
1.3.1 General overview 
 
The sympathetic nervous system (SNS), together with the parasympathetic 
nervous system (PNS), is part of the autonomic nervous system (ANS), 
responsible for the involuntary actions of the body such as control of heart rate, 
intestinal/glandular activity and smooth muscle relaxation/contraction. The SNS 
and PNS act in a complementary manner: while the PNS is in charge of the "rest-
and-digest" or "feed-and-breed" response, the SNS activates the "fight and flight" 
response. 
The SNS originates in thoracic and lumbar regions of the spinal cord and, among 
other activities, controls the body's response during a perceived threat. Its neuronal 
pathways are very fast, composed of two different sets of neurons: those that have 
their cell bodies within the spinal cord, called pre-synaptic, and those whose soma 
resides in ganglia outside the central nervous system (CNS), called post-synaptic. 
Pre-synaptic neurons release acetylcholine that targets post-synaptic neurons. 
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Through an electrochemical impulse along the axons of the latter, there is a 
secretion of noradrenaline at nerve varicosities close to the peripheral target. One 
of the targets of pre-synaptic neurons is the adrenal gland, responsible for the 
release of adrenaline, noradrenaline and glucocorticoids into the bloodstream. 
 
1.3.2 Role of the SNS in the vasculature 
 
SNS innervation is much more predominant around arteries than veins as shown in 
Figure 1.8. In fact, sympathetic neurons and arteries are associated during 
embryonic development, when these neurons differentiate into ganglia alongside 
the main embryonic artery, the dorsal aorta (Eichmann and Brunet, 2014). 
 
The SNS is involved in the vasoconstriction of arteries and arterioles through the 
release of noradrenaline at the varicosities that are in close contact with smooth 
muscle cells (SMCs) of arteries that lie along the axon. The activation mechanism 
consists of the stimulation of adrenergic receptors expressed by the SMCs 
(Westcott and Segal, 2013). A defective arterial innervation and vasoconstriction 
response is associated with cardiovascular disease. Increased SNS activity is 
responsible for heart complications such as infarction, transient ischemia or stroke. 
These diseases follow a circadian rhythmicity, having the highest number of events 
in the morning, which may also be due to the fact that the SNS has a higher activity 
at this time of the day in humans (Malpas, 2010). 
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Figure 1.8 Innervation status of the vasculature by SNS. Adrenergic input seems to 
have different roles in physiology and pathophysiology; however, the function of 
sympathetic nerve activity in vascular pathophysiology is still not completely understood. 
Tyrosine hydroxylase (TH) immunostaining (green) of a mouse artery (A) labeled with 
anti–smooth muscle antibody (SMA) (red). L, lymphatic vessel; V, vein (Eichmann and 
Brunet, 2014). 
 
Apart from the role in arteriolar vasoconstriction, sympathetic nerves may be 
involved in post-ischemic revascularization processes though three different 
mechanisms: first, the release of catecholamines, particularly noradrenaline. In 
animals which lack catecholamines (dopamine-beta-hydroxylase (Dbh)-/- mice, 
deficient in dopamine beta-hydroxylase, the enzyme mediating the conversion from 
dopamine to noradrenaline), post-ischemic revascularization was reduced 
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(Chalothorn et al., 2005), as well as revascularization after the resection of the 
femoral artery in Adrb2-/- mice (Ciccarelli et al., 2011). Second, the SNS has been 
described to be a crucial modulator in hematopoietic stem and progenitors cell 
(HSPC) mobilization from bone marrow via the regulation of CXCL12 (Mendez-
Ferrer et al., 2008). HSPC mobilization and homing to ischemic tissues seems to 
be crucial in arteriogenesis (Segers and Lee 2008), highlighting the importance of 
the SNS in this process. Third, regulation of inflammation by the SNS suggests that 
sympathetic nerves can influence the growth of large arteries through the 
communication with immune cells (Silvestre, 2008). Dbh−/− mice show a decrease 
in the number of leukocytes accumulated in the wall of bypass collateral arteries 
and reduced revascularization, suggesting the link between sympathetic nerve–
derived adrenergic activation and arterial growth via effects on immune cells 
(Chalothorn et al., 2005) 
 
 
1.3.3 Adrenergic receptors 
 
The adrenergic receptors (AR) are a class of G-protein-coupled receptors that are 
targeted by the catecholamines noradrenaline and adrenaline. Although similar in 
structure, different receptors regulate the diverse physiological processes by 
controlling the synthesis or release of a variety of second messengers or the 
activity of ion channels. Each major type of receptor shows preference for a 
particular class of G-protein (e.g., α1 to Gq; α2 to Gi) (Westfall, 2009). 
 
There are two classes of adrenergic receptors: alpha (α1 and α2) and beta (β1, β2 
and β3). α-ARs (1 and 2 subtypes) are found in some cells such as alveolar and 
peritoneal macrophages or under certain pathologic conditions (Heijnen et al., 
1996).  
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At the tissue level, β-adrenergic receptors are found in all organs which are related 
with growth such as skeletal muscle, adipose tissue and some neuro-endocrine 
organs (Yang and McElligott, 1989). They also play an important role in modulating 
cardiovascular responses. From a therapeutic perspective β1ARs in the heart (the 
target for β-blockers), and β2ARs in the lungs (the target for β2 agonists), are the 
most important (Stein, 2012).   
 
 
1.3.4 Adrenergic control of the immune system 
 
Signals from the CNS are sent via the SNS to peripheral tissues by 
catecholamines through adrenergic receptors. Noradrenaline and adrenaline target 
cells through the two groups of adrenergic receptors described above (Elenkov et 
al., 2000). Both receptors are found in innate immune cells, whereas T and B cells 
appear to only express β2 adrenergic receptors (Nance and Sanders, 2007). As 
mentioned above, in general, the most abundant receptor in leukocytes is the β2 
adrenergic receptor. The highest density is found on natural killer cells (NKs) and 
the lowest in T helper (Th) cells. In fact, no β2 adrenergic receptors were observed 
in the case of Th2 cells (Elenkov et al., 2000). This reduced expression of β2 
adrenergic receptors in adaptive cells of the immune system could be due to the 
fact that the nervous system is perfectly located to regulate immediate nonspecific 
inflammatory responses (Sternberg, 2006). 
It has been reported that the SNS exerts an inhibitory role in inflammation, through 
a direct innervation of immune organs. Noradrenaline can drastically inhibit the 
production and secretion of TNF-α in response to LPS (Ignatowski et al., 1996). In 
addition, SNS targeting of the adrenal gland releases glucocorticoids, which have 
been described to suppress maturation, differentiation and proliferation of all 
immune cells, including dendritic cells (DCs) and macrophages. They are also 
involved in the inhibition of NFκB, which, after its translocation to the nucleus, is 
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responsible for the upregulation of other pro-inflammatory molecules (Ghosh et al., 
1998). Glucocorticoids are also involved in the decrease in expression of cell 
adhesion molecules, such as ICAM-1, E-Selectin (Cronstein et al., 1992) and 
VCAM-1 (Atsuta et al., 1999), as well as of the chemokines CC-chemokine ligand 2 
(CCL2) and CXC-chemokine ligand 8 (CXCL8) (Miyamasu et al., 1998). 
As previously mentioned, the relation between the SNS and circadian rhythms in 
terms of immunity lies in the ability of the SNS to synchronize the circadian release 
of pro-inflammatory mediators with the external environment. Once environmental 
information is processed in the master clock (SCN), the signal is sent via two 
different methods: via direct innervation of the SNS to peripheral organs (e.g. bone 
marrow, liver or spleen) along the arterial tree, or via hormones, targeting the 
adrenal gland and secretion of noradrenaline, adrenaline and glucocorticoids. The 
level of noradrenaline exhibits a daily rhythmicity reaching its peak during the 
active phase (Maestroni et al., 1998). This leads to different effects on leukocyte 
migration, proliferation and function. In addition, apart from adrenaline and 
noradrenaline, the adrenal medulla contains and secretes a high quantity of IL-6 
and TNF-α in response to inflammatory stimuli, such as LPS and IL-1 (α and β) 
(Papanicolaou et al., 1996). 
Rhythmic leukocyte recruitment to tissues is also regulated by the SNS. Mice 
deficient in the β2 or β3 adrenergic receptors (Adrb2
-/- and Adrb3-/-) showed no 
more oscillations in their recruitment to either bone marrow or skeletal muscle. In 
line with these observations, administration of β2 or β3 adrenergic receptor agonists 
(clenbuterol or BRL37344, respectively) enhanced bone marrow engraftment after 
transplantation, through upregulation of cell adhesion molecules such as P-
Selectin, E-Selectin and  VCAM-1 (Scheiermann et al., 2012).  
Recent work has described an interaction of Nestin+ cells with the SNS. Nestin, 
which is an intermediate filament protein known as a neural stem/progenitor cell 
marker, is expressed in undifferentiated CNS cells during development (Suzuki et 
al., 2010). Nestin+ cells located in the bone marrow are sympathetically innervated 
alongside arteries and express β3 adrenergic receptors on their surface. In bone 
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marrow, they are involved in the regulation of the hematopoietic stem cell niche via 
expression of CXCL12 and other niche factors (Mendez-Ferrer et al., 2008). 
These studies all point to an important role of the SNS in the control of the immune 
system and in the circadian rhythmicity of leukocyte recruitment. Since post-
capillary venules, where this phenomenon usually takes place, are devoid of 
adrenergic innervation, the purpose of this thesis was to try to elucidate how these 
adrenergic stimuli reach veins to regulate leukocyte infiltration to tissues. 
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2 Materials and Methods 
 
2.1 Animals 
 
2.1.1 Mouse strains 
Bmal1flox/flox and Icam1-/- mice were obtained from Jackson Laboratories. Ng2Cre 
mice were a gift from Konstantin Stark. These lines were crossed to generate mice, 
which lack Bmal1 specifically in arteriolar pericytes (Bmal1flox/floxxNg2Cre). LyE-
GFP mice, which express GFP fluorescence in the myeloid lineage, were a gift 
from Markus Sperandio. Cx3cr1GFP/+ mice were a gift from Christoph Reichel. 
These mice express GFP fluorescence in monocytes, dendritic cells, NK cells, and 
microglia under control of the endogenous Cx3cr1 locus.  
7-8 week old wild-type C57BL6/N control mice were acquired from Charles River. 
Mice were housed under a 12h:12h light-dark cycle with ad libitum access to food 
and water. All experimental procedures were performed according to German 
legislation and approved by the Regierung of Oberbayern. 
 
2.1.2 Genotyping 
 
Ear samples were digested in 200µl lysis buffer (5mM EDTA, 200mM NaCl, 0.2% 
SDS in 100mM Tris-HCl, pH 8.5) containing proteinase K (1µl, 1,5U per sample) at 
55°C overnight. After centrifugation (10 min RT at 14000rpm), the supernatant was 
transferred to an Eppendorf tube containing 200µl isopropanol to induce DNA 
precipitation. Tubes were then inverted and centrifuged 10 min at 14000 rpm. 
Supernatant was carefully discarded and DNA pellets were resuspended in 100µl 
Tris-EDTA (TE) buffer and incubated for 1h at 37°C before being used in the PCR 
reaction mix (see Table 2.1). 
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Component Volume (µl) 
Water 8.6 
Master Mix (2X) 10 
Forward primer (10µM) 0.2 
Reverse primer (10µM) 0.2 
DNA 1 
 
Table 2. 1 PCR reaction mix for genotyping. 
 
Samples were initially denatured at 94°C for 3 minutes, followed by 35 
amplification cycles of DNA denaturation (94°C, 30 sec), primer annealing (55°C 
for Bmal1flox/flox, 30 sec) and DNA polymerization (72°C, 30 sec), with a final 
extension step (72°C, 2 minutes). Assessment of the Cre gene was performed by a 
denaturation at 95°C for 3 minutes, followed by 38 cycles of DNA denaturation 
(95°C, 20 sec), primer annealing (62°C, 30 sec), and DNA polymerization (72°C, 
30 sec), with a final extension step (72°C, 10 minutes). Primer sequences were 
used as shown in the following table (Table 2.2): 
 
Primer Sequence (5’  3’) 
Bmal1 (Arntl) FW  ACT GGA AGT AAC TTT ATC AAA CTG 
Bmal1 (Arntl) RV  CTG ACC AAC TTG CTA ACA ATT A 
Generic Cre FW GCG GTC TGG CAG TAA AAA CTA TC 
Generic Cre RV GTG AAA CAG CAT TGC TGT CAC TT 
 
Table 2. 2 PCR primers used for genotyping 
 
PCR products were run on a 1% agarose-TAE gel, using GelRed in order to 
visualize the bands with an ultraviolet light on a Gel iX20 Imager (Bioolympics). A 
DNA ladder (ThermoFisher Scientific) was used to check the band size from the 
products (Figure 2.1). 
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Figure 2.1 PCR genotyping gels. Examples from Bmal1 and Cre amplification. 
Heterozygous (Bmal1flox/wt; bands 327bp and 431bp) and homozygous for the 
Bmal1flox/flox (431bp), as well as Cre+ bands (324bp) were detected. 
 
  
Cre
+ WT H
2
O 
WT H
2
O fl/fl fl/+ 
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2.1.3 Tamoxifen preparation and treatment 
 
To induce recombination in the CreERT2 mice (Cdh5 and Bmx), 8-10 week old 
mice were injected i.p. with tamoxifen daily for 5 consecutive days, changing 
injection site left/right every day. Tamoxifen was dissolved in corn oil (20mg/ml) 
with incubation at 37°C for 1h. Any remaining crystals were dissolved by incubating 
a further 3-4h at room temperature on a rotator to constantly invert the tube.  
 
 
2.2 Multichannel fluorescence intravital microscopy (MFIM) 
 
2.2.1 Carotid artery and jugular vein imaging 
 
Mice were anesthetized by i.p. injection of ketamine (100mg/kg), xylazine 
(20mg/kg) and acepromazine (1%). A ventral incision was made in the neck and 
the carotid artery and jugular vein were exposed. A knot was tied around the 
sternocleidomastoid muscle and the muscle was pulled to the side. Surgical knots 
were placed above (short suture thread) and below (long suture thread) the tendon 
and a cut was made in the middle, to sever the tendon. Two knots were then tied 
around the bone and used to pull it to the side. A similar model was described in 
the paper by Chevre and colleagues (Chevre et al. 2014). After this preparation, 
the neck and the underlying vessels were treated topically with TNF-α (150µg in 
100ml PBS) for 2h prior to imaging (Figure 2.2A).  
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Figure 2.2 Carotid artery/jugular vein in vivo imaging. (A) Carotid artery/jugular vein 
preparation. (B) Epifluorescence microscopy images from carotid artery (left) and jugular 
vein after 2h topical TNF-α stimulation and intra-arterial injection of anti-CD11a-PE 
antibody. 
 
A catheter was inserted in the femoral artery for administrating fluorescence-
conjugated antibodies (1µg). Images were acquired on a fixed-stage microscope 
Axio Examiner.Z1 for bright field, inclined illumination, DIC-IR/VIS and 
epifluorescence, with motorized objective and condenser focusing as well as 
motorized reflector turret, in combination with a Colibri LED excitation system 
(Zeiss) (Figure 2.3). 
 
 
B 
A 
CD11a 
Carotid artery 
100µm CD11a 
Jugular vein 
100µm 
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Figure 2.3 Epifluorescence microscope set-up. Axio Examiner.Z1 microscope (left). 
Colibri light system (right).  
 
Quantification of adherent cells (defined as no obvious movement for at least 30s) 
in the carotid artery and jugular vein was performed manually and plotted per 
vessel. Since the size was not always constant, cells per area were calculated with 
the formula for the lateral surface area of a cylinder (2πr x length), divided by two 
as only one side of the vessel was visualized. In the case of the carotid, two 
cylinders were considered for the calculation due to the branching of the vessel. 
In order to measure the mean fluorescence intensity (MFI) from adherent cells, the 
Zeiss Blue Zen software was used. Circular masks were drawn on the cells (aprox. 
10 cells per vessel) and by selecting the maximum threshold value, area and 
intensity were calculated, as shown in Figure 2.4. 
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Figure 2.4 Representative example of mean fluorescence intensity measurement in 
adherent cells. (A) Circular masks were drawn around the area of interest (red line) and 
those areas were colored in red (B). (C) Cell areas with ID number (column A), size in μm2 
(column B) and mean intensity (arbitrary units) (column C).  
 
The intensity values given by the software were used as the mean fluorescent 
intensity for each cell. 
B 
B A 
C 
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2.2.2 Cremaster muscle imaging 
 
Mice were anesthetized with Fentanyl (0,5mg/kg), Midazolam (5mg/kg) and 
Medetomidine (0,5mg/kg) via i.p. injection. Cremaster preparation was performed 
as explained in a previous publication (Scheiermann et al. 2012). Through a central 
incision of the scrotum, the right testis was exposed. The cremaster muscle 
surrounding the testis was opened ventrally in a zone with less vasculature, using 
careful electrocautery to cut the muscle and at the same time stop any bleeding, 
and spread over a plexiglas cube of a custom-made microscopy stage (Figure 
2.5). Epididymis and testicle were detached from the cremaster muscle by 
electrocautery and placed back into the peritoneum. During the procedure as well 
as after surgical preparation, the muscle was superfused with warm buffered saline 
(0.9% NaCl). A catheter was inserted in the femoral artery for administration of 
antibodies. TNFα was injected i.p. or in the scrotum 3h before the imaging in order 
to visualize leukocyte adhesion in arterioles, since this phenomenon does not 
occur in steady-state conditions in these vessels. 
 
 
Figure 2. 5 Cremaster muscle preparation. Cremaster muscle preparation set-up (A). 
Blood flow in the cremaster microvasculature was checked using bigger magnification after 
surgery (B). 
A B 
56 
 
 
One of the advantages of the cremaster muscle in intravital microscopy is that it is 
very thin, which allows the use of transmitted light microscopy for imaging the 
microvasculature. Leukocyte migration can be visualized without using 
fluorescence imaging, as shown in the following picture (Figure 2.6). Another 
positive aspect of the cremaster muscle is that multiple vessels can be easily 
screened in the same mouse.  
 
 
  
 
 
 
 
 
Figure 2.6 MFIM of the cremasteric microcirculation. Rolling leukocytes, surrounded by 
white lines, were visualized in the microvasculature using brightfield microscopy (63X). 
 
 
Unlike the imaging of carotid artery or jugular vein, breathing is not an issue in the 
imaging process of the cremasteric microcirculation. In addition, using different 
fluorescently-conjugated antibodies, leukocyte phenotypes can be studied in more 
detail (Figure 2.7A). Results are reported as number of adherent cells/area, with 
the area defined as (2πr x l) and where r is the radius (diameter/2) and l is the 
length of the vessels. Adherent cells were defined as cell with no obvious 
movement for at least 30s (Figure 2.7B). 
 
A 
10µm 
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Figure 2.7 Cremaster muscle MFIM. (A) Microscope images of a cremasteric venule 
visualized with the 63x objective (Epifluorescence microscope). CD11b-PE was used as a 
myeloid marker, CD62L-APC for L-Selectin expression and BSA-coated fluorescent beads  
as a marker for cell activation. (B) Quantification of leukocyte adhesion (cremasteric 
venule), 20x objective.  
 
2.3 Immunofluorescence on frozen sections 
 
Carotid artery and jugular vein tissues were harvested without any perfusion after 
2h topical stimulation with TNF-α, embedded in OCT (TissueTek) and frozen on 
dry ice. No method to stop the vessels collapsing was needed. 10µm cross-
sections were cut on a cryostat (Leica) and stained with antibodies as detailed in 
Table 2.4. Methanol was used for fixation and goat serum (20% in PBS) for 
blocking in order to minimize unspecific antibody binding. Tissues were 
permeabilized by 0,5% Triton X-100. All images were acquired on an 
epifluorescence microscope (Axio Examiner.D1, Zeiss), equipped with 405, 488, 
563 and 655 nm LED light sources. As example, a representative picture is shown 
in the Figure 2.8.  
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Figure 2.8 Representative fluorescence imaging picture. Picture from a jugular vein 
10µm section stained with ICAM-1-PE (A), PECAM-1-APC (B). Brightfield (C) was 
obtained with transmitted light microscopy and merged (D) in order to visualize the whole 
structure. 
 
To quantify protein expression levels, analyses were performed on immunostained 
sections using a mask based on PECAM-1 staining, in combination with other 
antibodies, with the help of the Zeiss Blue Zen software. 
 
As shown in Figure 2.9A, a profile (red line) was drawn surrounding the area of 
interest (jugular vein, in this example). Positive areas for PECAM-1 (APC, shown in 
blue) were then used to generate a mask of the endothelium, shown in yellow (B). 
Within this PECAM-1 mask, mean fluorescence intensities of other fluorescently-
stained adhesion molecules were quantified. In the Figure 2.9C, the mean 
intensity values for the areas positive for PECAM-1 and the antibody of interest 
(ICAM-1, conjugated to PE) are shown. Areas smaller than 10µm2 were not 
considered in calculations as these often represented noise.  
ICAM-1 PE PECAM-1 APC 
A B 
C D 
Brighfield Merged 
50µm 50µm 
50µm 50µm 
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Figure 2.9 Representative example of quantitative expression analyses.  (A) A mask 
using PECAM-1 expression was drawn around the area of interest (red line) and PECAM-
1 positive pixels were colored in yellow (B). (C) PECAM-1 areas with ID number (column 
A) and size in μm2 (column B). The MFIs for each region are represented in column C 
(PECAM-1) and column D (ICAM-1). Areas smaller than 10 µm2 were discarded.  
C 
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2.4 Adoptive transfer and flow cytometry experiments 
 
To investigate the recruitment of leukocytes from blood to the vessels, adoptive 
transfer experiments were performed and donor-labeled-cells recruited in the 
tissues were measured. In order to prepare donor cells, spleen and bone marrow 
from donor mice were harvested and donor cells isolated. Single cell suspensions 
were made by flushing bone marrow with cold PBS and smashing spleen gently 
through a 40 µm cell strainer (ThermoFisher Scientific). Cells were lysed with red 
cell lysis buffer for 5 min, then 5 ml PBS were added to stop the lysis reaction. 
Cells were spin down at 1300 rpm for 5 min and resuspended in cell incubation 
buffer (PBS, 0.2%BSA, 2mM EDTA) and counted on a cell counter (ProCyte DX 
cell counter). Bone marrow and spleen cells were mixed with a ratio of 50:50, and 
labeled with 1.5 µM CFSE for 20 min at 37 °C. After washing 3 times with PBS, 
cells were resuspended in PBS and 20X106 cells were injected intravenously in 
each recipient mouse, which simultaneously were stimulated with TNFα topically 
on the carotid and the jugular. Two hours later, carotid and jugular were harvested 
from recipient mice and digested for performing flow cytometry. 
For identifying different leukocyte subsets in blood, cells were gated from total 
white blood cells (WBC) counts, from which the different leukocyte subsets were 
distinguished by specific surface markers. Blood cells were gated from live cells 
and singlets. Then leukocyte subsets were identified by different combinations of 
antibodies. CD115 and Gr-1 for differentiation of neutrophils; inflammatory 
monocytes (IM) and non-inflammatory monocytes (NIM); CD4, CD8 and B220 for 
identifying lymphocytes; NK1.1 and CD3 for NK cells and NKT cells; Siglec-F and 
CCR3 were used for eosinophil. 
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2.5 Functional blocking of adhesion molecules and chemokine 
receptors  
 
In order to investigate the role of ICAM-1, VCAM-1, CXCL1, CXCL2 and CCL2 in 
leukocyte adhesion in the macrovasculature, 200µg of blocking antibodies or 125 
µg CXCR2 and CCR2 antagonists were injected i.v. per mouse 1h before 
stimulation with TNF-α and 3h before performing in vivo imaging analyses. In the 
case of chemokine receptor antagonists, 1% Tween80, 5% DMSO in PBS were 
used as vehicle. 
 
2.6 Denervation techniques 
 
2.6.1 Chemical sympathetic denervation (6-OHDA) 
 
As indicated in the Figure 2.10, mice were injected twice before the experiment 
with 6-hydroxydopamine (6-OHDA), which is used to selectively destroy 
dopaminergic and noradrenergic neurons in the body. The initial dose consisted of 
100mg/kg, followed two days later by a dose of 250mg/kg. The experiment was 
performed three days later. 6-OHDA was prepared in ascorbic acid solution at 
20mg/ml (in PBS). 
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Figure 2.10 6-OHDA treatment scheme.  6-OHDA was administrated on day 1 
(100mg/kg) and 3 (250mg/kg) and the analysis was performed on day 5. 
 
 
 2.6.2 Surgical sympathetic denervation (SCGx) 
 
The superior cervical ganglion is located underneath the carotid bifurcation. Using 
forceps to carefully pull apart the carotid artery, the ganglion was identified and 
removed unilaterally by blunt dissection with the forceps. On the other side, an 
analogous manipulation was performed without transecting the ganglion (sham). 
Animals were sutured and left to recover for 4 weeks in order to re-establish blood 
leukocyte counts to steady-state levels, using the absence of inflammation as an 
indicator to proceed. 
 
2.7 β2 adrenergic receptor antagonist treatment 
 
To block β2 adrenergic receptor function, the antagonist butoxamine was 
administered via i.p. injection (5mg/kg); 2h prior to imaging for acute experiments 
or for five days in a row for chronic experiments. 
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2.8 Thrombosis assay  
 
An initial dose of 100µl fluorescein isothiocyanate (FITC)-coupled dextran (2.5%) 
was administrated intravenously to mice and fluorescence was checked until it 
reached 1800 (arbitrary units, AU). Fluorescence was kept constant and to verify 
comparable intravascular FITC concentrations among experimental groups, digital 
images were taken from each vessel and the mean fluorescence intensity was 
measured (Bihari et al., 2010). As shown in Figure 2.11, FITC phototoxicity was 
induced using a 488nm epifluorescence excitation source. This leads to energy 
absorption by the dye locally within the vessel and to endothelial cell damage with 
the formation of a thrombus as a consequence. Occlusion time was quantified for 
multiple vessels in each mouse (3 venules and 3 arterioles of the same size, 60µm 
and 40µm respectively) at different time points. 
 
Figure 2.11 Set-up of phototoxicity-induced thrombus formation. Fluorescence was 
measured in order to keep it constant during the experiment (left). 488nm light was used 
for inducing FITC phototoxicity and occlusion time was quantified.  
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2.9 RNA isolation 
 
Tissue samples were homogenized in 200µl Trizol (QiAzol, QiAgen) in 
(innuSPEED Lysis Tubes. In particular, P model was used, which is a 0.5 ml tube 
with screwing cap (green) containing optimized ceramic beads (2.4 - 2.8 mm) from 
Analytik Jena) and a homogenizer (SpeedMill PLUS, Analytik Jena), which 
mechanically disrupts the tissue due to the up- and down movement of the beads. 
Homogenized samples were centrifuged at maximum speed of 14000 rpm for 10 
min at 4°C. The supernatant was transferred to a new tube and 40µl chloroform 
was added. After shaking vigorously for 15 seconds, samples were incubated for 2-
3 minutes and centrifuged at 12000 rpm for 15 minutes, 4°C. Following 
centrifugation, three layers were visible: a lower organic phase (proteins and 
lipids), middle phase (denatured proteins and genomic DNA) and an upper 
aqueous phase (RNA). The upper phase was transferred to a new tube. RNA 
precipitation was induced with 100µl isopropanol and incubation for at least 1h at -
20°C. Following 30 minutes centrifugation at maximum speed at 4°C, the resulting 
pellet was washed with 75% ethanol. Samples were centrifuged for 15 min and 
resuspended in RNAse-free water in combination with 1U DNAse per sample 
(ThermoFisher Scientific). After 30 minutes incubation at 37°C, samples were 
purified using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s 
instructions. RNA samples were stored at -80°C. 
 
2.10 Reverse transcription 
 
RNA concentration and quality were measured using a NanoDrop LITE (Thermo 
Fisher Scientific). 100-200 ng RNA were reverse-transcribed into cDNA using the 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems), in 
accordance to the manufacturer’s instructions. cDNA samples were stored at -
20°C. 
65 
 
2.11 Quantitative real-time PCR 
 
Q-PCR was performed with SYBR Green on a StepOnePlus Real-Time PCR 
System (Applied Biosystems). The primer concentration used was 0.5µM. The 
PCR protocol consisted of one cycle at 95 °C (10 min) followed by 40 cycles of 
95 °C (15 s) and 60-64 °C depending upon primers used (1 min). Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was used as a housekeeping gene. The 
sequences of the oligonucleotides used can be found in the following table (Table 
2.3). 
 
 
Primers  Sequence Annealing(°C) 
Adrb2_F 
Adrb2_R 
GTA CTG TGC CTA GCC TTA GCGT 
GGT TAG TGT CCT GTC AAG GAGG 
60 
Adrb3_F 
Adrb3_R 
TCT AGT TCC CAG CGG AGT TTT CAT CG 
CGC GCA CCT TCA TAG CCA TCA AAC C 
60 
Bmal1_F 
Bmal1_R 
AGA GGT GCC ACC AAC CCA TA 
TGA GAA TTA GGT GTT TCA GTT CGT CAT 
62 
Bmal1_F 
Bmal1_R 
CCT AAT TCT CAG GGC AGC AGA T 
TCC AGT CTT GGC ATC AAT GAG T 
60 
Ccl2_F 
Ccl2_R 
TCTCTTCCTCCACCACCATGC 
AGCTTCTTTGGGACACCTGCTG 
60 
c-fos_F 
c-fos_R 
ATG GGC TCT CCT GTC AAC ACA C 
ATG GCT GTC ACC GTG GGG ATA AAG 
60 
Clock_F 
Clock _R 
CAA AAT GTC ACG AGC ACT TAA TGC 
ATA TCC ACT GCT GGC CTT TGG 
62 
Cry1_F 
Cry1_R 
CTC GGG TGA GGA GGT TTT CTT 
GAC TTC CTC TAC CGA GAG CTT CAA 
62 
Cxcl1_F 
Cxcl1_R 
GCTGGGATTCACCTCAAGAA 
TGGGGACACCTTTTAGCATC 
60 
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Cxcl2_F 
Cxcl2_R 
AGTTTGCCTTGACCCTGAAGC 
AGGCTCCTCCTTTCCAGG 
60 
Dbh_F 
Dbh_R 
GAT CTC ATC ATG CTC TGG ACT G 
CTG GTA GTC TTG CTG GGA ATC 
60 
Gapdh_F 
Gapdh_R 
TGT GTC CGT CGT GGA TCT GA 
CCT GCT TCA CCA CCT TCT TGA 
60 
GRa_F 
GRa_R 
GAA GGA AAC TCC AGC CAG AA 
CAG CTA ACA TCT CGG GGA AT 
60 
Icam1_F 
Icam1_R 
GGA CCA CGG AGC CAA TTT C 
CTC GGA GAC ATT AGA GAA CAA TGC 
60 
Nr1d1_F 
Nr1d1_R 
GAT AGC TCC CCT TCT TCT GCA TCA TC 
TTC CAT GGC CAC TTG TAG ACT TC 
60 
Nr1d2_F 
Nr1d2_R 
TCA TGA GGA TGA ACA GGA ACC 
GAA TTC GGC CAA ATC GAA C 
60 
Per1_F 
Per1_R 
TGA GAG CAG CAA GAG TAC AAA CTC A 
CTC GCA CTC AGG AGG CTG TAG 
60 
Per2_F 
Per2_R 
GTC CAC CTC CCT GCA GAC AA 
TCA TTA GCC TTC ACC TGC TTC AC 
60 
Rora_F 
Rora_R 
CTC GAG ATG CTG TCA AGT TTG G 
CGG CGT ACA AGC TGT CTC TCT 
60 
Rory_F 
Rory_R 
CTC AGC GCC CTG TGT TTT TC 
TGA GAA CCA GGG CCG TGT AG 
60 
Sele_F 
Sele_R 
CCC TGC CCA CGG TAT CAG 
CCC TTC CAC ACA GTC AAA CGT 
60 
Selp_F 
Selp_R 
GGT ATC CGA AAG ATC AAC AAT AAG TG 
GTT ACT CTT GAT GTA GAT CTC CAC ACA 
60 
Th_F 
Th_R 
GGT ATA CGC CAC GCT GAA GG 
TAG CCA CAG TAC CGT TCC AGA 
60 
Tnfr1_F 
Tnfr1_R 
GGG CAC CTT TAC GGC TTC C 
GGT TCT CCT TAC AGC CAC ACA 
60 
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Tnfr2_F 
Tnfr2_R 
CAG GTT GTC TTG ACA CCC TAC 
GCA CAG CAC ATC TGA GCCT 
60 
Vcam1_F 
Vcam1_R 
GAC CTG TTC CAG CGA GGG TCT A 
CTT CCA TCC TCA TAG CAA TTA AGG TG 
60 
 
Table 2.3 Primer sequences used for quantitative real time PCR 
  
 
2.12 Statistical analyses 
 
Statistical analyses were performed using GraphPad Prism 6 software. All data are 
represented as mean ± SEM. An unpaired student’s t-test was used for 
comparisons between two groups. One-way ANOVA followed by Tukey’s post hoc 
test or two-way ANOVA followed by Bonferroni’s post hoc test were used for three 
or more groups. Statistical significance was assessed as *p<0.05, **p<0.01, 
***p<0.001 and ****p<0.0001.   
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2.13 Antibody list 
 
Antibody Dye Clone Reactivity Company Quantity Use 
CD106 
(VCAM-1) 
PE 
429 
MVCAM.A 
anti-m Biolegend 1:50 IH 
CD106 
(VCAM-1) 
 M/K-2.7 anti-m BioxCell 
200µg/ 
mouse 
Blocking 
CD115 PE AFS98 anti-m Biolegend 1:100 FACS 
CD11a PE M17/4 anti-m Biolegend 1µg 
In vivo 
imaging 
CD11b PE M1/70 anti-m Biolegend 1µg 
In vivo 
imaging 
CD3 
PE/DZL5
94 
17A2 anti-m Biolegend 1:100 FACS 
CD31 
(PECAM1) 
Alexa 
Fluor647 
Mec13.3 anti-m Biolegend 1:100 
Immuno-
histochem 
CD4 
Brilliant 
Violet 
570™ 
RM4-5 anti-m Biolegend 1:50 FACS 
CD45R/B2
20 
PE/Cy7 RA3-6B2 anti-m/h Biolegend 1:300 FACS 
CD54  
(ICAM-1) 
PE YN1/1.7.4 anti-m Biolegend 1:50 IH 
CD54 
 (ICAM-1) 
 YN1/1.7.4 anti-m BioxCell 
200µg/ 
mouse 
Blocking 
CD62L 
(L-Selectin) 
APC MEL-14 anti-m Biolegend 1µg 
In vivo 
imaging 
CD62L  
(L-Selectin) 
PE 2PH1 anti-m Biolegend 1:50 IH 
CD62P  
(P-Selectin) 
PE Psel.KO2.3 anti-m/h Biolegend 1:50 IH 
CD8a APC/Cy7 53-6.7 anti-m Biolegend 1:500 FACS 
DAPI    Biolegend  FACS 
Gr-1 
PerCP/Cy
5.5 
RB6-8C5 anti-m Biolegend 1:300 FACS 
Isotype  LTF-2 Rat IgG2b BioxCell 
200µg/ 
mouse 
ICAM-1 
isotype 
Isotype  HRPN Rat IgG1 BioxCell 
200µg/ 
mouse 
VCAM-1 
isotype 
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Ly6-G PE 1A8 anti-m 
BD 
Biosciences 
1µg 
In vivo 
imaging 
NF H  Polyclonal anti-h/r/m Millipore 1:200 IH 
NF M  Polyclonal anti-h/r/m Millipore 1:200 IH 
NK1.1 
Alexa  
Fluor700 
PK136 anti-m ebioscience 1:100 FACS 
Siglec-F 
Alexa 
Fluor647 
E50-2440 anti-m 
BD 
bioscience 
1:100 FACS 
TH  Polyclonal anti-m Millipore 1:1000 IH 
α-Smooth 
Muscle 
Cy3 1A4 anti-m 
Sigma 
Aldrich 
1:200 IH 
 
Table 2. 4 Antibody list. (h-human, m-mouse, r-rat). 
 
 
2.14 Reagents 
 
Compound Company Quantity Use 
Isopropanol Sigma-Aldrich 1:3/1:2 DNA/RNA precipitation 
6-OHDA Sigma-Aldrich 
100mg/kg (1
st
 day) 
250mg/kg (3
rd
 day) 
Chemical sympathetic 
denervation 
Acid Ascorbic MERCK 20mg/ml 6-OHDA antioxidant 
Butoxamine (β2 
antagonist) 
Sigma-Aldrich 5mg/kg 
β2 adrenoreceptor 
blocking 
CCR2 antagonist Tocris 5mg/kg CCR2 blocking 
Chloroform Sigma-Aldrich 1:5 RNA isolation 
Corn oil Sigma-Aldrich 50µl/injection (5 days) 
Cre recombination 
induction 
CXCR2 
antagonist 
Tocris 5mg/kg CXCR2 blocking 
DMSO Sigma-Aldrich 5% 
Chemokine receptor 
block. (vehicle) 
DNA ladder Nippon genetics europe 5 µl Electrophoresis gel 
DNAse ThermoFisher Scientific 1:50 
DNA digestion (RNA 
isolation) 
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Fluorescein 
isothio-cyanate-
dextran 
Sigma-Aldrich 2,5%  (in saline) Thrombosis assay 
gelRed Biotium 1:20.000 Electrophoresis gel 
Goat serum Abcam 20% 
Antigen blocking 
(immunohist.) 
Methanol Sigma-Aldrich 200µl 
Fixation 
(immunohistochemistry) 
OCT Tissue-Tek Manufact. instructions 
Specimen matrix 
(immunohistoc.) 
PFA (4%) Sigma-Aldrich 200µl 
Fixation 
(immunohistochemistry) 
Proteinase K Thermo Scientific 600U/ml (20mg/ml) Tail/ear digestion 
QIAzol Qiagen 200ul/sample RNA isolation 
Retrotranscription 
kit 
Applied Biosystems Manufact. instructions 
RNA retrotranscription 
to cDNA 
RNeasy Mini Kit Qiagen Manufact. instructions RNA purification 
SYBR green Thermo Fisher Scientific 1:2 (5µl/well) qPCR 
Tamoxifen Sigma-Aldrich 1mg/injection (5 days) 
Cre recombination 
induction 
TNF-α R&D Systems 
0.15µg carotid/jugular 
0.5µg cremaster 
Induction of 
inflammation 
Triton X100 Sigma-Aldrich 0,5% 
Permeabilization 
(immunohistoc.) 
TWEEN80 Sigma-Aldrich 1% 
Chemokine receptor 
block. (vehicle) 
 
Table 2. 5 Reagents list 
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3 Results 
 
3.1. Differences in leukocyte adhesion between arteries and 
veins 
 
Recent studies provide a molecular link between circadian rhythms and the 
immune system. Leukocyte counts oscillate according to the phase of physical 
activity of the organism. For instance, in blood, the peak is observed during the 
behavioral resting phase, while the recruitment of leukocytes to tissues occurs 
preferentially during the active phase of the organism (Scheiermann et al., 2013). 
In order to fully understand this phenomenon in large calibre vessels, we 
performed quantitative in vivo fluorescence microscopy of the carotid artery and 
the jugular vein after 2h tumor necrosis factor (TNF)-α stimulation, every 4h over 
the whole day (from ZT1 until ZT21; Zeitgeber Time, time after the onset of light). 
Using very low, non-blocking, doses of CD11a (LFA-1)-PE conjugated antibody we 
quantified the number of adherent cells to the endothelium in both vessels (Figure 
3.1A). Clear diurnal rhythmicity in cell adherence was observed in both vessels, 
but with different phases. While the cell number was higher at ZT1 (8:00 am) in the 
carotid artery, the peak was significantly delayed in the jugular vein and appeared 
at ZT17 (midnight) (Figure 3.1B). In contrast, the lowest recruitment in the carotid 
artery was found at ZT17, the time of peak adhesion in the jugular. To facilitate 
comparison between the two vessels, data were plotted by fold change with 
respect ZT1 adhesion in carotid (Figure 3.1C) and the biggest discrepancies were 
found at ZT1 and ZT17. Therefore all subsequent experiments were focused on 
these two time points. 
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Figure 3.1 Diurnal oscillations in leukocyte adhesion in large vessels. (A) 
Epifluorescence microscopy images from carotid artery (left) and jugular vein (right) after 
2h TNF-α stimulation. Cells were labeled with CD11a-PE antibody and adherent cells 
classed as those that did not move for 30s. (B) Quantification of adherent cells at different 
time points of the day in intervals of 4h (n= 4-13 mice), one-way ANOVA **p < 0.01, ***p < 
0.001. (C) Normalized carotid and jugular adhesion data. 
 
In order to validate these observations without antibody labeling to rule out 
potential off-target effects, we performed the same in vivo imaging approach of the 
carotid and jugular vein after 2h TNF-α stimulation in LyE-GFP mice (Figure 3.2A). 
These mice express GFP in myeloid cells, and we could report comparable results: 
higher leukocyte recruitment in the carotid artery in the morning (ZT1), and in the 
jugular vein at ZT17 (Figure 3.2B). 
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Figure 3.2 Differences in leukocyte recruitment in LyEGFP mice between morning 
and night. (A) Epifluorescence microscopy images from carotid artery (upper row) and 
jugular vein at ZT1 and ZT17 after TNF-α stimulation in mice that express GFP in myeloid 
cells. (B) Cell adhesion quantification in carotid artery and jugular vein (n = 4-7 mice), t-test 
*p < 0.05, **p < 0.01.  
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To confirm if this phenomenon was exclusive to the macrovasculature, or was 
representative of a broader tissue context, we next imaged the cremaster muscle 
microvasculature, where venules and arterioles are located side by side in the 
same tissue. TNF-α was injected into the scrotum 3h before the in vivo imaging 
procedure. We observed similar results as in the macrovasculature (Figure 3.3A); 
a higher recruitment in the arterioles in the morning and the opposite pattern in the 
venules (Figure 3.3B). This was thus indicative of a mechanism of broader 
relevance for the whole vasculature. 
 
 
Figure 3.3 Differences in leukocyte adhesion in microvasculature. (A) 
Epifluorescence microscopy image from a venule in the cremaster muscle after 3h TNF-α 
stimulation. CXCR1-GFP mice showed GFP labeled inflammatory monocytes and 
neutrophils were labeled with Ly6G-PE. (B) Cell adhesion quantification in arterioles and 
venules (n = 5 mice), t-test ***p < 0.001, ****p< 0.0001. 
 
We next quantified the surface expression levels of the integrins LFA-1 (CD11a) 
and Mac-1 (CD11b) on the adherent cells in the large caliber vessels in situ. No 
oscillation was observed for LFA-1 expression in either vessel (Figure 3.4). Mac-1, 
in contrast, oscillated but in the same manner for carotid and jugular, suggesting 
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that the differences observed in leukocyte adhesion were not due to the leukocyte 
phenotype but the microenvironment. 
 
 
 
 
 
 
 
 
Figure 3.4 Differences in β2-integrins expression on adherent leukocytes.  LFA-1 and 
Mac-1 mean fluorescence intensity from adherent leukocytes (CD11a+ or CD11b+ cells) in 
carotid artery (red) and jugular vein (blue) at different times of the day, after 2h TNF-α 
stimulation (n= 5-8 mice), one-way ANOVA **p < 0.001, ***p < 0.0001, ns, not significant.  
 
To verify if these differences were driven by the microenvironment, we performed 
adoptive transfer assays where we injected donor cells - harvested from bone 
marrow and spleen and labeled with CFSE - from mice kept at the same time 
simultaneously into recipients that were phase-shifted to ZT1 and ZT17. Labeled 
cells were injected 2h prior to harvesting the vessels and mice were stimulated 
simultaneously with TNF-α as described before. Carotid artery and jugular vein 
were harvested and digested in order to perform flow cytometry (Figure 3.5A). We 
observed oscillations in the numbers of CFSE+ recruited cells in artery and vein 
and with the same peaks as before; higher numbers of cells in the morning in the 
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carotid artery and the opposite for the jugular vein (Figure 3.5B), even though the 
leukocytes were from the same time point. This confirmed the important role of the 
microenvironment in this phenomenon. 
 
 
 
 
 
 
 
Figure 3.5 Relevance of the microenvironment in CFSE+ cells homing. Gr1+ cells 
from CFSE+ injected cells found in carotid artery (red) and jugular vein (blue) at ZT1 and 
ZT17 after 2h TNF-α stimulation (n =12-15 mice),  t-test *p < 0.05. 
 
3.2 Involvement of cell adhesion molecules and chemokines 
in diurnal leukocyte recruitment 
 
Endothelial cells play a critical role in leukocyte adhesion, since they are physically 
located between tissues and blood, where this process occurs. Leukocyte 
recruitment is mediated by cell adhesion molecules and chemokines, some of 
which are expressed by endothelial cells in a circadian manner (Scheiermann et 
al., 2013). To address if critical molecules involved in adhesion were oscillatory 
over the day, we harvested the whole vessels after TNF-α stimulation for 2h at 
different time points and isolated RNA. qPCR analyses  showed a 24h oscillation in 
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Icam1, Vcam1, Sele and Selp, which peaked at night in the jugular vein (Figure 
3.6). In the case of the carotid artery, only Icam1 expression oscillated significantly.  
 
Figure 3.6 Cell adhesion molecule oscillations after inflammation. qPCR results of 
cell adhesion molecules from whole vessels, carotid (red) and jugular (blue), after 2h TNF-
α stimulation at different time points during the day (n =3-6 mice), one-way ANOVA *p < 
0.05.  
 
In addition, we could report daily oscillations of the chemokines Cxcl1, Cxcl2 and 
Ccl2, involved in myeloid cells trafficking in both vessels as well, with inverted 
phases in the carotid artery and the jugular vein (Figure 3.7). This suggests that 
the inflammatory response between arteries and veins dramatically differs over 
24h. 
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Figure 3.7 Chemokine oscillations over 24h in an inflammatory scenario. qPCR 
results of chemokine expression from whole vessels, carotid artery  (red) and jugular vein 
(blue), after 2h TNF-α stimulation at different time points during the day (n =3 mice), one-
way ANOVA *p < 0.05.   
 
We next investigated whether changes in RNA levels of cell adhesion molecules 
correlated with protein levels. For that, we used OCT frozen sections of isolated 
vessels after TNF-α stimulation. Using staining for PECAM-1 (CD31), as a marker 
for endothelial cells, in combination with other antibodies for cell adhesion 
molecules, we detected corresponding protein oscillations for ICAM-1 and VCAM-1 
specifically in endothelial cells (Figure 3.8). 
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Figure 3.8 ICAM-1 and VCAM-1 protein oscillations over 24h during inflammation. 
ICAM-1 and VCAM-1 mean fluorescence intensities (MFI) in endothelium from carotid 
artery (red) and jugular vein (blue), at different time points during the day after 2h TNF-α 
stimulation (n = 3-6 mice), one-way ANOVA *p < 0.05.   
 
Since ICAM-1 oscillatory expression phase-matched with the number of adherent 
leukocytes, we then performed in vivo quantitative imaging of cell adherence in 
Icam1-/- mice. When imaging the carotid artery of these mice at ZT1 and ZT17 
(Figure 3.9), numbers of CD11a+ adherent cells no longer oscillated. Comparable 
observations were noticed in the jugular vein, where we could not detect 
differences between ZT1 and ZT17 as we did in the control mice, indicating the 
importance of this molecule in the time-of-day-dependent recruitment of leukocytes 
in both vessels. 
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Figure 3.9 Leukocyte recruitment to large vessels in Icam1-/- mice. In vivo quantitative 
imaging of CD11a+ cells in carotid artery and jugular vein from Icam1-/- mice after 2h TNF-
α stimulation at ZT1 versus ZT17 (n= 8-9 mice), t-test *p < 0.05, **p < 0.01,  normalized to 
ZT1 levels. 
 
We next blocked ICAM-1 or VCAM-1 with antibodies and performed the same 
procedure of imaging after 2h TNF-α stimulation in both vessels. In agreement with 
the Icam1-/- data, the oscillations were not seen any more either in carotid artery or 
jugular vein with an antibody targeting ICAM-1. The same effect was observed 
when VCAM-1 was blocked (Figure 3.10) 
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Figure 3.10 Importance of ICAM-1 and VCAM-1 in oscillatory recruitment in large 
vessels. In vivo quantitative imaging of CD11a+ cells in carotid artery and jugular vein 
after 2h TNF-α stimulation at ZT1 versus ZT17. ICAM-1 and VCAM-1 were blocked with 
anti-ICAM1 or anti-VCAM1 antibodies. (n= 4-16 mice), t-test ***p < 0.001, ****p<0.0001, 
normalized to ZT1 levels. 
 
 
Similar results were obtained when we injected chemokine receptor antagonists 
against CXCR2 and CCR2 in the jugular vein but only for CCR2 in the carotid 
artery (Figure 3.11). This suggested the importance of the chemokines CXCL1 
and CXCL2 in the vein, and CCL2 in both vessels. These results demonstrated 
that distinct rhythms in the expression of adhesion molecules and chemokines in 
arteries and veins were critical determinants for the different leukocyte adhesion 
patterns we observed.  
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Figure 3.11 Functional role of chemokines in oscillatory leukocyte recruitment in 
large vessels. In vivo quantitative imaging of adherent CD11a+ cells in carotid and jugular 
vein after 2h TNF-α stimulation at ZT1 versus ZT17. CCR2 and CXCR2 were blocked with 
antagonists. (n= 4-6 mice), t-test *p < 0.05, normalized to ZT1 levels. 
 
3.3 Similar circadian oscillations in arteries and veins 
 
In collaboration with Prof. Dr. Henrik Oster, University of Lübeck, we examined 
whether overall circadian rhythms were different between arteries and veins. They 
used an mPer2Luc mouse strain, in which a firefly luciferase gene has been 
knocked-in to the terminal exon of the clock gene Per2, producing a PER2::LUC 
fusion protein as described (Yoo et al. 2004). Using these animals, the aorta was 
harvested as a proxy for the arterial vascular bed and the vena cava as a proxy for 
the venular vascular bed. Both vessel segments were cultured for multiple days in 
tissue culture dishes. Luciferase expression exhibited noticeable circadian 
fluctuations in artery and vein, with a more pronounced rhythm in artery and 
differences in the peak times, peaking a few hours earlier in the vein than in the 
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artery (Figure 3.12). This indicated that underlying clock gene expression profiles 
in arteries and veins might be different.  
 
 
 
 
 
 
 
 
 
Figure 3.12 PER2 daily oscillations in arteries and veins. Differences in luminescence 
between samples from artery or vein (left). Peak time comparison between vein and artery 
(right).  
 
However, when we checked the expression of core circadian genes in these 
tissues (Bmal1, Clock, Per1, Per2 and Cry1) they all showed high overlap, peaking 
and troughing at the same times in the light cycle both in steady state (Figure 
3.13) and TNF-α-induced inflammatory conditions (Figure 3.14). These data 
indicated that it was not the differences in the underlying rhythmicity of tissues that 
was driving the observed difference in oscillations but that an additional factor 
might regulate leukocytes differently in a timely manner between arteries and 
veins. In addition, TNF-receptor expression was not rhythmic in either arteries or 
veins (Figure 3.15). 
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Figure 3.13 Circadian clock genes oscillations in arteries and veins in steady state 
conditions. Clock gene expression was analyzed by qPCR from RNA extracted from 
whole vessels, carotid artery (red) and jugular vein (blue), in steady state conditions at 
different time points during the day. A significant effect of time was observed for all genes, 
but only Rev-Erba showed a difference between vessels (n = 6 mice), two-way ANOVA *p 
< 0.05. 
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Figure 3.14 Circadian clock gene oscillations in arteries and veins in inflammatory 
conditions. Clock gene expression was analyzed by qPCR from RNA extracted from 
whole vessels, carotid (red) and jugular (blue), after 2h TNF-α stimulation at different time 
points during the day. Significant oscillations were observed for all genes, with no 
difference between vessels.  (n = 3-4 mice), two-way ANOVA. 
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Figure 3.15 Tnfr1 and Tnfr2 oscillations in large vessels.  TNF-α receptors 1 and 2 
were measured by qPCR in steady state conditions from RNA from whole vessels every 
4h during a day (n = 6 mice), one-way ANOVA. 
 
3.4 Sympathetic control of circadian leukocyte recruitment in 
arteries and veins 
 
The sympathetic nervous system (SNS) is an important orchestrator of rhythmicity 
in peripheral tissues, so we decided to investigate if its disruption at different levels 
could have an effect in leukocyte adhesion. First, we targeted the SNS systemically 
using a treatment with the compound 6-OHDA and performed in vivo imaging at 
ZT1 and ZT17 (Figure 3.16). This resulted in a lack of oscillation in adherent cell 
numbers in both vessels.  
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Figure 3.16 Leukocyte recruitment in animals with no sympathetic input. Mice were 
treated with 6-OHDA, a drug which disrupts sympathetic innervation, one week before the 
analysis. In vivo imaging was performed at ZT1 and ZT17, quantifying CD11a+ cells after 
2h TNF-α stimulation (n = 5-8 mice), t-test *p < 0.05 normalized to ZT1 levels. 
 
To assess the functional role of direct sympathetic innervation in this process, we 
surgically denervated the sympathetic contribution to vessels locally by cutting the 
superior cervical ganglion unilaterally. While the contralateral, nerve-intact, side still 
exhibited rhythmicity in leukocyte adhesion (Figure 3.17), local denervation 
resulted in a loss of oscillations. 
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Figure 3.17 Leukocyte recruitment in animals after surgical denervation. Mice were 
unilaterally denervated by surgical removal of the superior cervical ganglion (SCG) one 
month before the analysis. In vivo imaging was performed at ZT1 and ZT17, quantifying 
adherent CD11a+ cells after 2h TNF-α stimulation (n = 5-12 mice), t-test  **p < 0.01 
normalized to ZT1 levels. 
 
When measuring the cell adhesion molecule levels in these tissues (Figure 3.18), 
the differences between the expression at ZT1 and ZT17 were diminished in Icam1 
and Vcam1 in the case of the carotid artery and in Icam1, Vcam1, Sele, and Selp 
in the jugular vein from denervated vessels. 
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Figure 3.18 Cell adhesion molecule expression after surgical denervation. RNA from 
control and denervated vessels after 2h TNF-α stimulation was isolated and cell adhesion 
molecules checked by qPCR (n = 5-7 mice), t-test *p < 0.05, **p < 0.01. 
 
We next wanted to determine which adrenergic receptors were involved in the 
rhythmicity observed in leukocyte recruitment in arteries and veins. For this, we 
injected the β2 antagonist butoxamine 2h before the imaging procedure. After 
blocking β2 adrenergic receptors pharmacologically, we observed an ablation in 
the time-of-day difference in leukocyte adhesion between ZT1 and ZT17 in the 
artery but not in the vein (Figure 3.19). This effect was restricted to ZT1, 
suggesting the importance of β2 adrenergic signaling in the early morning.  
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Figure 3.19 Leukocyte recruitment in animals after acute β2 adrenergic receptor 
blockade. β2 antagonist was injected i.p. 2h before the analysis. In vivo imaging was 
performed at ZT1 and ZT17, quantifying CD11a+ cells after 2h TNF-α stimulation (n = 6-11 
mice), t-test, *p < 0.05, **p < 0.01, ***p < 0.001 normalized to ZT1 levels. 
 
 
In order to link this observation with Icam1 expression, we isolated RNA from 
vessels and performed qPCR analyses (Figure 3.20). There was a downregulation 
of Icam1 after blocking β2 adrenergic receptors in the carotid artery at ZT1 but 
there was no effect in Icam1 expression in jugular vein at any of the two time 
points, which correlated with the lower number of recruited cells found at this time 
in the artery but not in the vein. 
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Figure 3.20 Icam1 expression after acute β2 adrenergic receptor blockade. β2 
antagonist was injected i.p. 2h before the analysis. Vessels were collected at ZT1 and 
ZT17, after 2h TNF-α stimulation and Icam1 levels were checked by qPCR (n = 5-6 mice), 
t-test, *p < 0.05, **p<0.01 normalized to ZT1 levels. 
 
Building on this data, we next tested the effects of chronic  β2-adrenoreceptor 
antagonism, injecting the antagonist once a day, for 5 days in a row. After this 
chronic block of β2 adrenergic receptors, oscillatory recruitment was ablated in 
both vessels (Figure 3.21). 
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Figure 3.21 Leukocyte recruitment in mice after chronic β2 adrenergic receptor 
blockade. β2 antagonist was injected during 5 consecutive days before the analysis. In 
vivo imaging was performed at ZT1 and ZT17, quantifying adherent CD11a+ cells after 2h 
TNF-α stimulation (n = 4-7 mice), t-test *p < 0.05 normalized to ZT1 levels. 
In this set of experiments, no oscillation in Icam1 was observed with chronic 
antagonist treatment in both vessels (Figure 3.22). 
 
 
 
 
 
 
Figure 3.22 Icam1 expression after chronic β2 adrenergic receptor blockade. β2 
antagonists were injected i.p. during 5 consecutive days before the analysis. Vessels were 
collected at ZT1 and ZT17, after 2h TNF-α stimulation and Icam1 levels were checked by 
qPCR (n = 3-4 mice), t-test *p < 0.05. 
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Finally, we validated the importance of the β2 adrenergic receptors genetically by 
using Adrb2-/- mice. When measuring numbers of adherent CD11a+ cells in these 
mice at ZT1 vs ZT17 after 2h TNF-α stimulation, oscillations were also lost in the 
artery but inverted in the vein (Figure 3.23). 
 
 
 
 
 
 
 
Figure 3.23 Leukocyte recruitment in Adrb2-/- mice in inflammation. In vivo imaging 
was performed at ZT1 and ZT17, quantifying adherent CD11a+ cells after 2h TNF-α 
stimulation (n = 7-9 mice), t-test *p < 0.05 normalized to ZT1 levels. 
 
 
Icam1 expression in vessels obtained from the Adrb2-/- mice was also non-
oscillatory (Figure 3.24) according with the lack of oscillations in recruited 
leukocytes in both vessels. 
 
 
 
94 
 
 
 
 
 
 
Figure 3.24 Icam1 expression in Adrb2-/- mice. Vessels from Adrb2-/- mice were 
collected at ZT1 and ZT17, after 2h TNF-α stimulation and Icam1 levels were checked by 
qPCR (n = 8-9 mice), t-test *p < 0.05. 
 
 
3.5 Differences in adrenergic input between arteries and veins 
 
Although the sympathetic nervous system (SNS) has been shown to regulate 
circadian leukocyte recruitment (Scheiermann et al. 2012) it is not understood how 
adrenergic signals are transduced to veins, the main site of leukocyte recruitment, 
since sympathetic innervation is present in arterioles but not in small venules. In 
this part, we aimed to elucidate the mechanisms of signal transduction and the cell 
types involved.   
Tyrosine hydroxylase (TH) is the enzyme responsible for catalyzing the conversion 
of the amino acid L-tyrosine to L-3,4-dihydroxyphenalalanine (L-DOPA), which 
mediates neurotrophic factors release by the brain and CNS (Lopez et al. 2008). 
This factor is the precursor of catecholamines and TH is the rate-limiting enzyme in 
the catecholamine biosynthesis. TH is a thus a marker for adrenergic innervation, 
which can be combined with neurofilaments (NF) to label nerves. As shown in 
Figure 3.25, in the carotid artery we observed strong expression of both markers, 
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which was in stark contrast to the jugular vein, where the expression of these 
molecules was absent, indicating the lack of sympathetic innervation in this vein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.25 Sympathetic innervation in large vessels. Carotid artery (left) and jugular 
vein (right) were stained with CD31-APC (endothelial cells), SMA-PE (smooth muscle 
cells), and NF-488 (neurofilaments) or TH-AlexaFluor488 (tyrosine hydroxylase). Pictures 
were obtained with confocal microscopy (20x objective). 
 
Similarly, when we measured tyrosine hydroxylase expression in the 
microvasculature of the cremaster muscle (Figure 3.26), we only detected its 
presence in arterioles but not venules. 
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Figure 3.26 Sympathetic innervation in microvasculature.  Confocal microscopy 
pictures from cremaster muscle vasculature (10x objective) were obtained after staining 
endothelial cells (PECAM-1 488) and tyrosine hydroxylase (TH-PE).  
 
We confirmed TH expression analyses by qPCR in our model of denervation, 
where high expression of TH was detected at ZT1 in the carotid artery from the 
intact side (Figure 3.27). No TH was detected at ZT1 in carotid from the 
denervated side (data not shown) or in the jugular vein under all conditions tested. 
 
 
 
 
 
 
 
 
Figure 3.27 Tyrosine hydroxylase levels in large vessels. TH levels were measured by 
qPCR from RNA from carotid artery and jugular vein at ZT1 and ZT17 in steady state 
conditions. (n = 5-6 mice) t-test *p < 0.05. 
100µm 
vein 
Merged 
artery 
97 
 
Arterial innervation occurs at the level of NG2+ mural cells, the expression of which 
is restricted to arteries (Figure 3.28).  
 
 
 
 
 
 
 
 
Figure 3.28 NG2 expression in large vessels.  Confocal microscopy picture from jugular 
vein and carotid artery (10x objective). Tyrosine hydroxylase was stained with TH-488, 
arteriolar pericytes with NG2-PE and endothelial cells with PECAM-APC. 
 
We could detect these mural cells in contact with TH fibers at the cremaster 
microcirculation level as well (Figure 3.29). 
 
 
 
 
 
 
 
 
 
 
Figure 3.29 NG2 expression in microvasculature.  Confocal microscopy image from 
jugular vein and carotid artery (10x objective). Tyrosine hydroxylase was stained with TH-
Alexa488, arteriolar pericytes with NG2-PE and endothelial cells with PECAM-1-APC. 
TH NG2 
 PECAM 
Jugular Carotid 
100µm 
a 
v 
NG2 TH 
PECAM-1 
30µm 
98 
 
In order to investigate how the lack of rhythmicity could affect leukocyte trafficking, 
we combined Bmal1flox/flox animals with Ng2Cre-bearing animals, targeting 
arteriolar pericytes. Quantitative in vivo imaging with these mice after 2h TNF-α 
stimulation showed an ablation of the oscillations in adherent cells in the carotid 
artery. Surprisingly, oscillations in the jugular vein were altered as well, even 
though arteries were the genetic target of this approach (Figure 3.30). 
 
 
 
 
 
 
 
 
 
Figure 3.30 Leukocyte recruitment in Ng2Cre+ Bmal1flox/flox mice in inflammation. In 
vivo imaging was performed at ZT1 and ZT17, quantifying adherent CD11a+ cells after 2h 
TNF-α stimulation (n = 5-8 mice), t-test *p < 0.05 normalized to ZT1 levels. 
 
To assess the reduction of Bmal1 and Icam1 in carotid artery and jugular vein, we 
harvested both vessels after TNF-α stimulation. Bmal1 was reduced in both 
vessels, artery and vein (Figure 3.31), indicating that although the Cre was specific 
for arteriolar pericytes there was an effect in the vein. This was also seen for Icam1 
expression, which was reduced in both vessels. 
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Figure 3.31 Bmal1, Icam1 and Vcam1 expression in Ng2Cre+ Bmal1flox/flox mice. 
Carotid artery (red) and jugular vein (blue) from Ng2Cre+ Bmal1flox/flox mice were collected 
at ZT1 and ZT17, after 2h TNF-α stimulation and Bmal1, Icam1 and Vcam1 levels were 
checked by qPCR (n = 3-7 mice), t-test *p < 0.05 normalized to ZT1 levels. 
 
3.6 Clinical relevance: circadian thrombosis 
 
In order to investigate if the activation status of adherent leukocytes was different 
between adherent cells in venules or arterioles, we used in vivo quantitative 
imaging and L-selectin expression (Figure 3.32). L-selectin can be used as an 
activation marker of neutrophils, the lower this protein is expressed, the more 
activated the cell is. As shown in the Figure 3.32C, CD11b+ cells were more 
activated at ZT5 than at ZT17 in the arterioles and vice versa in the venules, 
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suggesting different activation states between the arteriolar and venular leukocytes 
at different time points over the day. 
 
 
 
 
 
 
 
 
 
 
Figure 3.32 L-selectin levels in adherent cells from arterioles and venules. 
Epifluorescence microscope pictures (20x objective) from the cremaster microcirculation. 
Myeloid cells were stained with Mac-1-PE and L-selectin-APC. (A) Schematic example 
from recruited leukocytes in a cremasteric venule in which Mac-1, L-selectin and integrin 
activity through BSA-coated beads (488) were measured. (B) L-selectin levels were 
measured in adherent Mac-1+ cells in arterioles (red) and venules (blue) at ZT5 and ZT17 
(mean fluorescence per cell), t-test **p < 0.01, ****p < 0.0001. 
 
 
We focused next on the interactions produced between neutrophils and platelets in 
order to assess the relevance of different activation states of adherent neutrophils 
in arterioles and venules in the cremaster muscle after 3h TNF-α stimulation, using 
in vivo imaging. In contrast with the observations made in venules, the number of 
platelets-neutrophil interactions was higher at ZT1 and lower at ZT17 in arterioles 
 
CRC 914 
r 
r 
Mac-1 L-selectin 
beads merged 
A 
B 
101 
 
(Figure 3.33).  This indicated a different phenotype in terms of activation in 
neutrophils or platelets found in arterioles and venules. 
 
 
 
 
 
 
 
 
Figure 3.33 Platelet-neutrophil interactions in arterioles and venules. Interactions 
between platelets and adherent neutrophils were measured at ZT1 and ZT17 in arterioles 
and venules. (n = 6-21 vessels), t-test *p < 0.05, ***p < 0.001. 
 
To test the relevance of our observations in pathology, we performed a thrombus 
formation model in the cremaster muscle. This method consists of injection of 
FITC-dextran i.v. to provoke phototoxicity of the compound after excitation with a 
laser of 488nm, which leads to damage in the endothelium and subsequent 
thrombus formation. The read-out was the occlusion time for the same-sized 
vessels we were targeting at different time points.  
 
 
In the case of the venular side, a 24h oscillation was found in the time of occlusion, 
where ZT2 (2h after the onset of light, 9am) was the time point when the vessels 
took longer to be occluded compared to a shorter time at ZT8. The inverted case 
was observed in the arterioles, as the fastest occlusion time occurred at ZT2 and at 
ZT8 the longest (Figure 3.34).  These results were in line with the activation status 
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data, indicating that a higher activation status of adherent leukocytes can lead to 
lower occlusion time in thrombosis. 
 
 
 
 
 
 
 
 
Figure 3.34 Circadian thrombosis in venules and arterioles. FITC-dextran phototoxicity 
was provoked by 488nm light in order to damage the endothelium and prompt thrombus 
formation in the cremaster microcirculation. Occlusion time was measured every 4h in 
venules and arterioles. ZT2 double-plotted in order to facilitate viewing, (n = 6-21 vessels), 
one-way ANOVA *p < 0.05. 
 
 
When we performed these thrombosis experiments in Ng2Cre Bmal1flox/flox mice at 
ZT2 and ZT8, oscillations were ablated, suggesting the importance of rhythmicity in 
arteriolar pericytes in this process (Figure 3.35). 
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Figure 3.35 Circadian thrombosis in venules and arterioles from Ng2Cre+ 
Bmal1flox/flox mice. Thrombus formation in the cremaster microcirculation from Ng2Cre+ 
Bmal1flox/flox mice. Occlusion was measured at ZT2 and ZT8 (n = 6-21 vessels), t-test *p < 
0.05, **p < 0.01.  
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4 Discussion 
 
Circadian rhythms have helped organisms to adapt their body to their external 
environment. The recent link between circadian rhythms and the immune system 
has become a fast-growing field over recent years. Many primary research papers 
and a growing number of reviews have reported oscillations in the immune system, 
both innate and adaptive (Arjona et al. 2012; Scheiermann et al., 2013; Druzd et 
al., 2014; Curtis et al. 2014; Labrecque and Cermakian 2015; de Juan et al. 2016).  
Of particular importance for this project is the role of the SNS in rhythmic leukocyte 
trafficking and acute inflammation. As the group of Prof. Paul Frenette showed 
previously, local adrenergic input was indispensable for circadian leukocyte 
recruitment to tissues (Scheiermann et al., 2012). Interestingly, as described in the 
literature, adrenergic innervation is generally only found in arteries but not in veins 
in rats (Marshall, 1982). In line with this publication, we did not detect sympathetic 
innervation in the jugular vein or smaller venules in mice. It is in these latter post-
capillary venules where leukocyte recruitment predominantly occurs in most 
organs, so how local adrenergic input can influence leukocyte trafficking in veins is 
unknown. The purpose of this thesis was to clarify the diverse mechanisms 
involved in leukocyte recruitment to arteries and veins, with respect to similarities 
and differences between vascular beds, in an inflammatory scenario and in a 
circadian manner. After using pharmacological, surgical and genetic approaches, 
our data point to an important role of arteries and artery-associated sympathetic 
nerves in regulating rhythmic leukocyte recruitment to veins. 
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4.1. Circadian differences in leukocyte recruitment between 
arteries and veins 
 
Rhythmic leukocyte trafficking has been previously shown to occur under steady 
state conditions (Scheiermann et al., 2012) and in inflammatory scenarios, where 
Nguyen and colleagues reported that Ly6CHI inflammatory monocytes exhibit 
diurnal variation, controlling their trafficking to sites of inflammation (Nguyen et al., 
2013). However, no study has ever distinguished between arteries and veins. 
There are several diversities when comparing arteries and veins, in terms of 
structure and function, as detailed in the introduction. In this study, we could show 
that leukocyte adhesion during inflammation follows circadian rhythmicity in both 
arteries and veins, but with opposite patterns. While the peak number of adherent 
cells was found at ZT1 (8:00h) in the carotid artery, and the trough at ZT17 (0:00h), 
the inverse was true for the jugular vein. Importantly, we could extend the 
relevance of these observations to the cremaster muscle microcirculation. This 
suggested that the phenotype was due to a vessel-intrinsic mechanism and not 
due to the tissue. Importantly, we detected similar time-of-day differences in arterial 
and venous blood, exhibiting higher leukocyte numbers at ZT1 compared to ZT13. 
This suggested that the differences observed in recruitment were not due to 
different numbers in circulating leukocytes in the arterial or venous compartments. 
We investigated whether adherent cells showed different expression of leukocyte 
adhesion molecules among the day. LFA-1 and Mac-1 were measured in situ in 
cells adherent to veins and arteries. We detected no difference between cells from 
artery or vein, suggesting that a microenvironmental effect was responsible for the 
observations. This hypothesis was confirmed by performing an adoptive transfer 
assay, where we could observe that even if injected cells were coming from the 
same donor, there were still differences in the recruitment between arteries and 
veins when the recipients were at different timing regimes: whereas the highest 
recruitment was found for the artery at ZT1 and the lowest at ZT17, the opposite 
case was observed in the vein. 
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In summary, this data suggested the differences in leukocyte recruitment in arteries 
and veins were not due to the leukocyte but the microenvironment. 
 
4.2. Cell adhesion molecules and chemokines are involved in 
circadian recruitment 
 
Cell adhesion molecules and chemokines are crucial in the leukocyte recruitment 
process. A circadian expression of different pro-inflammatory mediators such as 
cytokines, chemokines or cell adhesion molecules has previously been reported. 
For example, CCL2 and CXCL1 have been found to oscillate in serum from mice 
(Gibbs et al., 2012), as well as CXCL12 in bone marrow (Mendez-Ferrer et al., 
2008). In the case of cell adhesion molecules, ICAM-1 peaks at the onset of the 
activity phase in muscle endothelial cells, as well as E-selectin, P-selectin and 
VCAM-1 in endothelial cells from bone marrow (Scheiermann et al., 2012).  
The mechanisms of cell adhesion molecule upregulation in veins and arteries are 
identical (Nabah et al., 2005), but the distribution of ICAM-1, for instance, is 
different between the two vessels. Compared with arteries, venular endothelium 
expresses higher ICAM-1 levels in steady-state conditions. In addition, the luminal 
surface area of arteriolar ECs is roughly twice that of venular ECs, so they simply 
cannot reach sufficient surface density levels of ICAM-1 to promote leukocyte 
adhesion (Sumagin and Sarelius, 2006). This evidence, together with the higher 
pressure and velocity of the blood in arteries, could explain the absence of 
leukocyte adhesion in arterioles under normal situations. 
However, when we checked the expression of Icam1, Vcam1, Selp and Sele after 
induction of acute inflammation, a different upregulation profile between arteries 
and veins across the day was detected. In veins, there was a much higher 
expression of all of these transcripts at ZT17. In the case of artery, Icam1 was the 
only transcript that showed an oscillation, although at the protein level, both ICAM-
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1 and VCAM-1 matched our recruitment data. Additionally, we checked expression 
levels for the chemokines Cxcl1, Cxcl2 and Ccl2 and found they also oscillated in a 
completely different manner between arteries and veins; in phase with the 
adherent leukocytes and the cell adhesion molecules described previously. This 
indicated that arteries and veins have different oscillatory expression patterns in 
terms of cell adhesion molecules under inflammatory conditions. 
Since the ICAM-1 expression profile matched best with the recruitment data, 
functional assays were performed using ICAM-1 blocking antibodies. As a result, 
there was a lack of oscillations in recruitment to both vessels, implying the 
relevance of ICAM-1 in rhythmic leukocyte recruitment. We could confirm this 
observation using Icam1-/- mice and obtaining similar results. Furthermore, 
functional blocking of VCAM-1, CXCR2, or CCR2 also reduced differences of 
adhesion and rendered them arrhythmic, with the exception of CXCR2 in the 
artery, confirming the importance in their oscillatory expression in mediating 
adhesion rhythmicity. 
In conclusion, the diversity in the molecular signature of circadian expression of 
endothelial cell adhesion molecules and chemokines in arteries and veins are 
responsible for the shifted times in the recruitment process.  
 
4.3. Differences in recruitment are independent of circadian 
clock gene expression 
 
Clock genes are expressed in a rhythmic fashion in peripheral tissues, due to the 
existence of peripheral clocks that are entrained by humoral or neuronal cues from 
the SCN (central clock). Virtually every single cell has a molecular clock, which 
consists of auto-regulatory mechanisms of different transcription factors (Druzd et 
al., 2014). 
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Since clock genes are responsible for the circadian expression of clock controlled 
genes which can be differentially expressed in a tissue-specific manner (Motosugi 
et al. 2011), we wanted to verify if differences in clock genes expression could 
explain the differences in leukocyte recruitment to arteries and veins.  
In order to investigate if overall clock gene expression was altered between 
arteries and veins over the course of the day, we established a collaboration with 
Prof. Henrik Oster and his group at the University of Lübeck. They used the 
expression of one of the core clock proteins, PER2, fused with a luciferase reporter 
as a bioluminescent readout of clock phase. They noticed differences in circadian 
fluctuations between the aorta and the vena cava. They detected a higher 
amplitude in the artery than in the vein and that the peak time came earlier in the 
vein than in the artery, suggesting that clock gene expression could be different 
between those vessels. 
However, while we did observe a strong daily oscillation when we screened 
circadian clock gene expression (Bmal1, Clock, Per1, Per2 and Cry), we did not 
detect phase differences in carotid artery or jugular vein in steady state conditions 
or in an acute inflammatory scenario. In fact, clock gene expression profiles were 
similar to a previous study performed in samples from lymph nodes where, for 
example, Bmal1 was exhibiting its peak at ZT1 and ZT21, in antiphase with Per1 
and Per2, its negative regulators (Druzd et al., 2017). An exception was Nr1d1 
(Rev-Erb) expression, which was slightly different in expression between artery 
and vein. It would be interesting to study this difference further.  
This suggested that the differences reported in leukocyte recruitment were not due 
to differences in underlying clock gene expression but to additional factors. 
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4.4 SNS controls rhythmic leukocyte recruitment in arteries 
and veins 
 
The SNS is involved, among other activities, in different involuntary physiological 
processes associated with the body's response during a perceived threat. With 
respect to its role related to the vasculature, it plays a major part in the arteriolar 
control of vasoconstriction and blood pressure and post-ischemic revascularization. 
Of particular relevance for our study is the role of the SNS in the control of the 
immune system. Peripheral tissues are targeted by the SNS by the release of 
catecholamines (adrenaline and noradrenaline) acting on adrenergic receptors of 
the α and β subtype (Elenkov et al., 2000). Both types of adrenergic receptors are 
found in innate immune cells, whereas T and B cells appear only to express β2 
adrenergic receptors (Nance and Sanders, 2007). In fact, the β2 adrenergic 
receptor is the most abundant receptor in leukocytes. However, this receptor is not 
exclusively expressed in leukocytes but has a very broad distribution pattern. It can 
be found in other cells, such as endothelial cells (Howell et al., 1988). 
Previous studies have linked the SNS with rhythmicity in the immune system. In 
the case of circulating HSCs and their progenitors in the bone marrow, oscillations 
were described to be inversely correlated with the expression of the chemokine 
CXCL12, involved in homing. It was shown that Cxcl12 expression, as well as the 
release of HSCs, are under circadian control due to noradrenaline secretion by the 
SNS. Adrenergic input was described to locally target stromal cells (Nestin+) 
present in the bone marrow through their β3-adrenergic receptors. As a 
consequence, the transcription factor SP1 was decreased, leading to a quick 
downregulation of Cxcl12 (Mendez-Ferrer et al., 2008).  
In the case of T cells, neural signals through β2-adrenergic receptors are involved 
in a reduction in the egress of lymphocytes from lymph nodes causing an increase 
of lymphocyte numbers in LNs at night in mice (Suzuki et al., 2016). Another 
complementary publication described that by deleting Bmal1, rhythmic expression 
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of S1pr1 was abolished in T cells leading to non-oscillatory egress of lymphocytes 
(Druzd et al., 2017). 
In addition, leukocyte recruitment to tissues is under adrenergic control. Adrb2−/− 
and Adrb3−/− mice that express no β2- or β3-adrenergic receptors, respectively, 
show no more oscillations in recruitment to either BM or muscle tissue. According 
to these results, administration of β2- or β3-adrenergic receptor agonists 
(clenbuterol or BRL37344, respectively) was found to significantly improve BM 
engraftment after transplantation (Scheiermann et al., 2012). 
These studies are in line with our observations, as we could demonstrate that 
oscillations in leukocyte recruitment to arteries and veins were abolished after 
targeting the SNS. After chemical and surgical sympathetic denervation, 
differences in leukocyte recruitment between day and night, as well as in ICAM-1 
expression, were ablated, confirming the important role of the SNS in rhythmic 
recruitment in arteries and veins. Furthermore, we could demonstrate that β2 
adrenergic receptors were relevant in this phenomenon since administration of β2 
adrenergic receptor antagonists lead to a lack of oscillations in leukocyte 
recruitment in arteries and veins. These results correlated with the abolished 
rhythmicity in ICAM-1 expression. We could observe the same phenotype when we 
used Adrb2-/- mice. In summary, we could demonstrate the importance of the SNS, 
specifically β2 adrenergic receptors, in circadian leukocyte recruitment to arteries 
and veins. 
 
4.5 Arteries drive rhythmic recruitment in arteries and veins 
 
As shown with our previous experiments, there is a critical role of the SNS in 
leukocyte recruitment to arteries and veins in an inflammatory scenario. However, 
it appears that veins are not directly innervated by this system as we saw no 
sympathetic innervation of the jugular vein or in venules from the microvasculature. 
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Another indication of the absence of this adrenergic input was observed in the 
jugular vein, where tyrosine hydroxylase expression was not detected.    
Sympathetic nerves are in direct contact with smooth muscle cells in arterioles, so 
we hypothesized that pericytes were critical in receiving and transmitting local SNS 
signals to venules. In order to verify this idea, we made use of the differential 
expression profile of NG2 (neural/glial antigen 2), a marker of arteriolar pericytes, 
which is absent from veins (Murfee et al., 2005). We employed Ng2-cre targeted 
mice to ablate the core circadian gene Bmal1 in arterial Ng2+-mural cells (Ng2Cre 
x Bmal1flox/flox). Surprisingly, even if the lack of rhythmicity was induced only in the 
artery, we could no longer detect oscillations in leukocyte recruitment between day 
and night in both arteries and veins. According to these results, when checking the 
expression of Bmal1, Icam1 and Vcam1, we could detect a downregulation of 
these molecules in both vessels. This indicated that rhythms in the vein were 
affected by the artery. 
 
4.6 Different susceptibility in circadian thrombosis between 
arteries and veins   
 
Acute cardiovascular complications are the major cause of death in developed 
countries. Some cardiovascular diseases such as myocardial ischemia or infarction 
represent a higher risk during the morning in humans. In a study from Muller at al. 
they reported the highest number of infarcts was found between 10:00 and 12:00 in 
the morning (Muller et al., 1985). Leukocyte recruitment is of critical importance in 
vaso-occlusive crises, as shown in a model of sickle cell disease (Hidalgo et al., 
2009). Furthermore, there is a critical role of circadian leukocyte adhesion events 
in the onset of acute cardiovascular diseases (Scheiermann et al., 2012). Actually, 
in a recent publication, it has been described how CCR2 surface expression on 
Ly6CHI monocytes oscillates in a rhythmic manner, influencing cardiac monocyte 
recruitment after an acute ischemic event (Schloss et al., 2017). 
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L-selectin expression can be used as an activation marker on neutrophils, as it is 
shed over 24h in these cells (Casanova-Acebes et al., 2013). The lower expression 
of this protein is, the more activated the leukocyte has become (Zhang et al. 2015). 
Using in vivo quantitative imaging, we could measure the levels of L-selectin in 
adherent cells from arteries and veins, in phase with our previous observations. L-
selectin levels were lower in adherent cells in arteries in the morning and higher 
during the night, indicating that cells in the morning were more activated. Opposite 
results were obtained from the cells adherent in the venular side. This correlated 
with the data from neutrophil-platelet interactions. While the highest number of 
interactions was found in the morning in arteries, it was the opposite case for the 
veins, coinciding with the time of higher activation of the adherent cells in both 
vessels, respectively. Taken together, the intravascular activation status of the 
cells was in line with the leukocyte recruitment in arteries and veins.   
In order to test the relevance of these findings in our study, we checked the 
occlusion time in a thrombosis assay at different times of the day, comparing 
arterioles and venules. We observed a 24h oscillation in the venular side. The peak 
was found at ZT2 (09:00h) and the trough at ZT8 (15:00h). However, when 
checking the arteriolar side, the observations were completely the opposite. The 
time of the day when the arterioles occluded most quickly was ZT2 and the most 
slowly was ZT8. There was a second peak at ZT20 (03:00), agreeing with a 
previous publication by Westgate and colleagues in which they were performing 
the experiments in the femoral artery (Westgate et al. 2008) reporting similar 
results as ours in the arterioles. When using different core clock gene knock-out 
mice, this oscillatory pattern was abolished. Of special interest, a disruption in the 
diurnal variation in occlusion time but not in systemic blood pressure was noticed in 
Tie2Cre x Bmal1flox/flox mice, in which Bmal1 was specifically eliminated in 
endothelial cells. This suggested the importance of the microenvironment in the 
heightened susceptibility to vaso-occlusion at different times. 
When we used Ng2Cre x Bmal1flox/flox mice, a specific Cre for arteriolar mural cells, 
in order to induce lack of rhythmicity specifically in arteries, we could report an 
113 
 
ablation of the differences of occlusion time in both vessels, arteries and veins. 
This result suggested an influence from the artery to the vein in terms of 
rhythmicity. However, we do not know the mechanism, yet. We presume this effect 
is not dependent on humoral factors since adrenergic receptors were not oscillating 
significantly in artery or vein. Our hypothesis is that this arterial influence of the 
vein might be due to a physical transduction of a signal via connexins, for instance. 
Overall, the results from our experiments point to an important and previously 
unrecognized role of arteries in regulating rhythmic leukocyte recruitment to veins, 
which could have potential implications in driving time-of-day-dependent 
cardiovascular complications. 
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